Professional Documents
Culture Documents
Page 1
These course note have been compiled by Hayden Farquhar for the unit CAM101: Foundations of Medicine 1 in the degree Bachelor of Medicine and Bachelor of Surgery. They are not intended to be in the hands of anyone but the person who compiled it. Hayden Farquhar is not claiming this to be his own work; indeed this information is not correctly cited and it is never the intention of the compiler for this work to be reproduced, sold, or used by anyone other than himself, as a reference study aid. This note set omits the course components of cell biology and immunology.
Page 2
H I S T O L O G Y ................................................................................................................................................................................ 1 EPITHELIA......................................................................................................................................................................................... 1 Characteristics of epithelium:..................................................................................................................................................... 1 Classification of epithelium: ....................................................................................................................................................... 2 EPITHELIAL CELL SPECIALIZATION ................................................................................................................................................... 4 GLANDS AND GLANDULAR TISSUE .................................................................................................................................................... 8 CONNECTIVE TISSUE ...................................................................................................................................................................... 16 What is connective tissue? ........................................................................................................................................................ 16 Cells of connective tissue: ......................................................................................................................................................... 16 Fibroblasts ................................................................................................................................................................................ 16 Extracellular Matrix ................................................................................................................................................................. 17 Embryonic connective tissue: ................................................................................................................................................... 21 Loose connective tissue: ........................................................................................................................................................... 22 MUSCLE TISSUE.............................................................................................................................................................................. 30 Types of muscle tissue:.............................................................................................................................................................. 30 Cardiac muscle: ........................................................................................................................................................................ 33 NERVOUS TISSUE............................................................................................................................................................................ 36 Synapses:................................................................................................................................................................................... 38 Myelination of axons: ............................................................................................................................................................... 38 HISTOLOGY OF THE INTEGUMENTARY SYSTEM ............................................................................................................................... 42 Structures of the skin ................................................................................................................................................................. 42 Layers and tissues of the skin.................................................................................................................................................... 42 Epidermis .................................................................................................................................................................................. 42 Epidermis and dermis ............................................................................................................................................................... 44 Appendages of the skin.............................................................................................................................................................. 46 B I O C H E M I S T R Y N U T R I T I O N A N D M E T A B O L I S M ................................................................................... 49 AMINO ACIDS, PROTEINS AND ENZYMES ......................................................................................................................................... 49 Structure of amino acids and proteins ...................................................................................................................................... 49 Proteins ..................................................................................................................................................................................... 50 Protein and amino acid turnover in the body ........................................................................................................................... 51 Imbalances in protein and amino acid turnover ....................................................................................................................... 53 Enzymes..................................................................................................................................................................................... 54 Proteins and enzymes in diagnosis ........................................................................................................................................... 56 CARBOHYDRATES ........................................................................................................................................................................... 57 Structure of common carbohydrates in the body and in foods ................................................................................................. 57 Functions of glucose and glycogen ........................................................................................................................................... 58 Glucose and glycogen turnover in the body ............................................................................................................................. 59 Starches ..................................................................................................................................................................................... 60 Dietary fibre .............................................................................................................................................................................. 60 Glycosaminoglycans ................................................................................................................................................................. 60 Carbohydrates in diagnosis ...................................................................................................................................................... 60 Is carbohydrate essential in our diet? ...................................................................................................................................... 61 LIPID (FATS) ................................................................................................................................................................................... 61 Structure of fatty acids and triglycerides .................................................................................................................................. 61 Functions of fatty acids and triglycerides ................................................................................................................................. 62 Triglyceride and fatty acid turnover in the body ...................................................................................................................... 63 Specialised lipids ...................................................................................................................................................................... 64 Lipids in diagnosis and therapy ................................................................................................................................................ 65 Summary of fatty acid usage ..................................................................................................................................................... 65 MICRONUTRIENTS .......................................................................................................................................................................... 66 Some roles of vitamins .............................................................................................................................................................. 66 Roles of some minerals and trace elements .............................................................................................................................. 67 A HEALTHY DIET ........................................................................................................................................................................... 68 Nutrient Reference Values (NRV) ............................................................................................................................................. 68 Dietary guidelines for Australians, 2003 .................................................................................................................................. 68 METABOLISM BASIC PRINCIPLES .................................................................................................................................................. 70 Key metabolic situations ........................................................................................................................................................... 70 Key energy molecules: ATP, ADP and AMP ......................................................................................................................... 72 CATABOLIC AND ANABOLIC PROCESSES ......................................................................................................................................... 74 Key fuels used ........................................................................................................................................................................... 74 Fundamental process in catabolism oxidation ...................................................................................................................... 74 Aerobic catabolism ................................................................................................................................................................... 75 Fuel catabolism under anaerobic conditions is much less efficient ......................................................................................... 76 Page 3
Anaerobic processes (introduction and examples) ................................................................................................................... 76 B I O C H E M I S T R Y D N A C O M P O N E N T ................................................................................................................... 78 DNA STRUCTURE AND THE GENETIC CODE .................................................................................................................................... 78 Structure of DNA....................................................................................................................................................................... 78 DNA replication ........................................................................................................................................................................ 80 DNA REPLICATION AND REPAIR ..................................................................................................................................................... 82 G E N E R A L P A T H O L O G Y ................................................................................................................................................... 93 CELLULAR RESPONSES TO STRESS AND NOXIOUS STIMULI.............................................................................................................. 93 Common harmful cellular alterations ....................................................................................................................................... 94 Organelles involved in the cellular response to injury ............................................................................................................. 95 Cellular adaptations intracellular accumulations ................................................................................................................. 96 Tissue changes .......................................................................................................................................................................... 96 APOPTOSIS AND NECROSIS ............................................................................................................................................................. 97 Apoptosis ................................................................................................................................................................................... 98 Necrosis................................................................................................................................................................................... 101 INFLAMMATION ............................................................................................................................................................................ 104 Acute inflammation ................................................................................................................................................................. 104 The five cardinal signs of inflammation.................................................................................................................................. 108 TISSUE REPAIR, FIBROSIS AND REGENERATION ............................................................................................................................. 108 Outcomes of acute inflammation ............................................................................................................................................ 109 Healing of skin ........................................................................................................................................................................ 110 Factors impairing the ability of tissue to repair ..................................................................................................................... 111 Factors that promote repair.................................................................................................................................................... 111 Summary diagram ................................................................................................................................................................... 112 CHRONIC INFLAMMATION............................................................................................................................................................. 112 Chronic inflammation arises in the following circumstances: ............................................................................................... 113 Morphologic features of chronic inflammation ...................................................................................................................... 113 Mononuclear (macrophage) cell infiltration .......................................................................................................................... 113 Other cells involved in chronic inflammation ......................................................................................................................... 114 Granulomatous inflammation ................................................................................................................................................. 115 N E O P L A S I A ............................................................................................................................................................................. 117 GENERAL FACTS ABOUT NEOPLASIA ............................................................................................................................................. 117 NOMENCLATURE AND GENERAL PRINCIPLES ................................................................................................................................ 117 Benign tumours of mesenchymal (non-epithelial) origin........................................................................................................ 117 Benign tumours of epithelial origin ........................................................................................................................................ 117 Malignant tumours of mesenchymal (non-epithelial) origin .................................................................................................. 118 Malignant tumours of epithelial origin ................................................................................................................................... 118 TUMOUR MORPHOLOGY, BEHAVIOUR AND GROWTH .................................................................................................................... 119 General features...................................................................................................................................................................... 119 Tumour history ........................................................................................................................................................................ 119 Differentiation and anaplasia ................................................................................................................................................. 120 Dysplasia................................................................................................................................................................................. 121 Neoplastic angiogenesis.......................................................................................................................................................... 122 Local Invasion ......................................................................................................................................................................... 123 Metastasis ............................................................................................................................................................................... 124 Aetiology ................................................................................................................................................................................. 126 THE MOLECULAR BASIS OF CANCER ............................................................................................................................................ 127 Five fundamental principles underlie the molecular basis of cancer ..................................................................................... 127 The essential molecular alterations for malignant transformation ........................................................................................ 128 SKIN TUMOURS ............................................................................................................................................................................. 129 Naevi ....................................................................................................................................................................................... 129 Dysplastic naevus.................................................................................................................................................................... 130 Lentigo maligna ...................................................................................................................................................................... 131 Malignant melanoma .............................................................................................................................................................. 131 Squamous cell carcinoma ....................................................................................................................................................... 133 Basal cell carcinoma............................................................................................................................................................... 134 Benign skin neoplasms ............................................................................................................................................................ 135 H O M E O S T A S I S ...................................................................................................................................................................... 138 BODY FLUID COMPARTMENTS ...................................................................................................................................................... 138 Thirst mechanism .................................................................................................................................................................... 140 Regulation of water output...................................................................................................................................................... 141 Starling's Law of the Capillaries ............................................................................................................................................ 141 Page 4
Burns ....................................................................................................................................................................................... 143 HOMEOSTATIC FUNCTION OF THE SKIN ......................................................................................................................................... 145 Body heat ................................................................................................................................................................................ 145 Effect of variation of ambient temperature on skin temperatures .......................................................................................... 145 Functional relationships within the skin vasculature ............................................................................................................. 151 I N T R O D U C T I O N T O P H A R M A C O L O G Y .............................................................................................................. 155 PHARMACOLOGICAL PRINCIPLES.................................................................................................................................................. 155 What is a drug? ....................................................................................................................................................................... 155 Some basic pharmacological terminology .............................................................................................................................. 156 Potential drug targets: membrane bound enzymes ................................................................................................................. 156 Potential drug targets: G-protein coupled receptors ............................................................................................................. 156 Potential drug targets: ion channel receptor proteins ........................................................................................................... 156 Potential drug targets: transport proteins .............................................................................................................................. 156 More terminology.................................................................................................................................................................... 156 Polypharmacy ......................................................................................................................................................................... 157 DRUG DELIVERY ........................................................................................................................................................................... 157 Why are there different routes of drug delivery? .................................................................................................................... 157 Different routes of drug administration .................................................................................................................................. 158 Different forms of medication ................................................................................................................................................. 158 How drugs get to their site of action ....................................................................................................................................... 158 Oral administration ................................................................................................................................................................ 159 Parenteral administration ....................................................................................................................................................... 159 Drug prescription quantities ................................................................................................................................................... 159 Some common abbreviations and symbols used in pharmacology ......................................................................................... 160 BASIC PRINCIPLES OF RECEPTORS, LIGANDS, AND SECOND MESSENGER SYSTEMS........................................................................ 160 Drug action at the receptor can vary depending on the drug-target interaction ................................................................... 160 The four receptor superfamilies .............................................................................................................................................. 161 Exam question examples (from all Dr Foas lectures) ........................................................................................................... 165 THE DYNAMIC AND EXCITABLE CELL MEMBRANE ........................................................................................................................ 166 Why are membranes dynamic and excitable? ......................................................................................................................... 166 What is a membrane potential? .............................................................................................................................................. 166 The proteins responsible for maintaining the membrane potential ........................................................................................ 166 The resting membrane potential ............................................................................................................................................. 167 Electrical activity within neurons ........................................................................................................................................... 168 Why cells need a membrane potential .................................................................................................................................... 169
Page 5
Histology
Histology is the study of tissues, and cells in tissue formation. This course covers the histology of the four basic adult tissue types (epithelia, connective tissue, muscle and nervous tissue) as well as covering the structure and function of the integumentary system, concurrent with the integrated learning topics on the skin throughout the unit.
Epithelia
General facts about epithelium:
Epithelium covers the body surfaces, both internally and externally (i.e., a surface = covered by an epithelium. Two exceptions - joint cartilage and brain) Epithelium acts as a boundary or interface between different compartments within the body, or between the body and the external environment. I.e., compartmentalisation These boundaries and interfaces can facilitate: protection (skin) - resist abrasion, stop things getting in and out absorption (small intestine) - increase surface area trans-cellular transport of molecules - associated with absorption (e.g. lungs) (requires epithelium to be very thin for efficient exchange of gases - remember structure versus function) selective permeability (because of the abilities of the plasma membrane) filtration (kidney) - get rid of wastes and water excretion (kidney, intestines, skin) (this is eliminating metabolic waste products) secretion (glands, small intestine, kidney) (this is releasing chemicals from a cell) Epithelium forms all of the glands of the body (both endocrine (onto ducts; they have maintained their epithelial connection) and exocrine (into the bloodstream; they have not maintained their epithelial connection))
Characteristics of epithelium:
Cellularity - there is very little extracellular space between cells of epithelia, highly cellular Specialised contact between cells - cell junctions (these occur elsewhere of course) Polarity - apical, basal and lateral domains (and specialisations of cell junctions associated with these) Basal lamina (at the EM level) - (basement membrane at the LM level) - ALL epithelia sit on a basement membrane (anchorage) Supported by underlying connective tissue (lamina propria - general term) - both mechanical and nutritional support Avascular - doesn't have a vascular supply, so must receive nutrients from the underlying connective tissue, via diffusion or other methods Innervated - responds to stimuli (touch, pain, heat, etc.) Regeneration - can repair itself (e.g. in the skin, the stratum basale is highly mitotically active) Cell membrane specialisations - cilia, microvilli (not flagella because sperm is not epithelium!)
Page 1
Classification of epithelium:
First classification - number of cell layers Simple - one cell layer thick Stratified - more than one cell layer thick Pseudostratified - one cell layer with all cells touching the basemement membrane that gives the appearance of stratified. Not all cells touch the surface. Second classification - shape of cells (always on the apical or luminal surface - this is where we get the classification) 1. Squamous - wider than they are tall (flattened) 2. Cuboidal - as wide as they are tall (box!) 3. Columnar - taller than they are wide Note in some epithelia the shape of cells will differ from the apical to the basal portions. We always take the classification from the apical cells. Example - skin, where the apical cells are squamous, and the cells in the stratum basale can often be cuboidal to low columnar.
Simple squamous Simple cuboidal Simple columnar Stratified squamous Stratified cuboidal Pseudostratified ciliated columnar with goblet cells Urinary or transitional
Transitional epithelium:
Found only in the excretory passages of the urinary system, that is, the renal pelvis, ureters and bladder.
Page 3
Also called urinary epithelium, or urothelium. Stratified epithelium with domed cuboidal cells on the surface of the relaxed epithelium, and irregularlyshaped nuclei. The surface cells show cell membrane specialisations to allow for expansion of the organ (like plaques).
zonula occludens Adhering junctions zonula adherens macula adherens, or, desmosomes hemidesmosomes Communicating junctions gap junction or nexus
These junctions help to define the polarity of the cell. Their principal function is to control the passage of substances between adjacent, connecting cells. Occcluding junctions, called zonula occludens, have a beltlike distribution like a ribbon, internally bracing the cells. These junctions are particular evident between epithelial cells that have secretory or absorptive functions. This makes sense because once a cell secretes a product, it doesn't want the product seeping back next to the cell itself. The actual occluding part of the zonula occludens are intramembranous proteins, occludin and claudin, that "stitch" the membrane of adjacent cells together. This prevents substances passing through this junction. This means that if substances need to get through the epithelial layer, it must do so via the transcellular pathway.
Page 5
The zoluna adherens is also called the belt desmosome. It has a belt-like distribution. It is associated with actin filaments. In the diagram, it is the junction on the left (note the belt-like distribution). These cell junctions are for strength, and robustly hold cells together, but they are very leaky, and require the presence of occluding junctions to stop substances getting past the cells. Important - plasma membrane plaques are used as anchorage points by the actin filaments of the cytoplasmic skeleton. The cadherins (desmocollins and desmogleins) are transmembrane proteins.
This in an anchorage junction with a spot-like distribution. They have identical structure to zonula adherens except they are spots rather than a belt. Also, their plaques are associated with intracellular intermediate filaments, not actin filaments like in zonula adherens. There may be many macula adherens per cell.
Hemidesmosomes:
Hemidesmosomes are the cell junctions that link the basal domain of an epithelial cell to the basal lamina of the basement membrane. On the cellular side, intermediate filaments called tonofilaments are associated with intracellular plaques, which attach to anchoring filaments (laminin 5) in the basal lamina.
Page 6
These cell junctions essentially connect the cytoplasm of one cell to another. A gap junction is formed by connexons, which are a group of 6 channel-like proteins called connexins (notice the difference) that permit the passage of small molecules between adjacent cytoplasms. That is, six connexins = one connexon. This allows for coordinated action of multiple cells. Remember that electrochemical gradients can instigate intracellular responses? Well these gradients can be facilitated by gap junctions. This means that not every cell needs to be innervated. A key example of the use of the gap junction is the intercalated disks of the cardiac muscle cell.
Microvilli:
Microvilli (singular microvillus) are an apical surface modification. Microvilli are formed from a core of microfilaments (actin) that are extensions of the cytoplasm that contain a bundle of actin. Because they are extensions of the cytoplasm of the cell, they have the ability to greatly increase the surface area of the cell. In this manner, the microvilli can be very short on non-absorptive cells, to very long on highly absorptive cells (think of the small intestine). The benefits of increasing surface area depend on the function of the cell. It could increase the amount of plasma membrane proteins (like digestive enzymes or ion channels) or allow more room for endocytotic processes. At the LM level, because there are a large number of glycoproteins present at the end of long microvilli, in certain areas the microvilli form a brush border. Remember, lots of glycoproteins on the surface of cells all together are known as a glycocalyx.
Page 7
Microvilli are immotile. They do NOT move anything along the surface.
Stereocilia are elongated, immotile microvilli, and are thus poorly named. They are only found in two places: the epididymis of the male reproductive system, and the sensory cells of the ear. For the epididymis, they increase surface area for absorption, and in the ear they act as sensory receptors.
Cilia are much longer and thicker than microvilli. They have a core of microtubules (known here as an axoneme), which arise from an area just deep to the projection of the cilia from the plasma membrane, called the basal body. The axoneme is an arrangement of microtubules we term the 9+2 pattern: a ring of 9 pairs of microtubules with a pair in the middle. Each pair interacts with its neighbour via protein extensions called dynein arms. The dynein arms function as motor elements that enable the cilia to move. Cilia produce a whipping-like motion. Therefore they are responsible for the transport of surface materials. They can be found in the respiratory and female reproductive systems.
All glands form as downgrowths of epithelia. That is, the epitheliem grows downwards during the gland's development, and some cells differentiate into the secretory portion of the gland, and some cells differentiate into the ductal portion of the gland. If the gland retains its connection to the original surface epithelium, it is known as an exocrine gland. If the gland does not retain its connection to the original surface epithelium, it is known as an endocrine gland, and they release their secretions into the bloodstream.
Page 9
Within the lobules of alveolar and tubuloalveolar glands the secretory cells are arranged into groups called acini (acinus singular). Each acinus may be surrounded by several contractile cells called myoepithelial cells. These are modified epithelial cells whose cytoplasm have contractile properties that help the secretion move up the duct system. The duct from each acinus joins to form intercalated ducts (unlike the diagram above), which are lined by simple squamous epithelium. In salivary glands, intercalated ducts join into striated ducts. These ducts are lined by a simple cuboidal to low columnar epithelium, and have many basal infoldings that give them a striped appearance under histological section. These then join to form intralobular ducts, which join with others to form interlobular ducts, which are lined by pseudostratified cuboidal to low columnar epithelium. Interlobular ducts join to form intralobar ducts and intralobar ducts join to form lobar ducts, which are lined by stratified cuboidal to columnar epithelium. To clarify:
Page 10
Acinus secretes into Intercalated ducts--------------simple squamous epithelium--------------------many of these join into (Striated ducts---------salivary glands only-----------basal infoldings-------------simple cuboidal to low columnar--------many of these join into) Intralobular ducts-------------------------------------------------------------------------many of these join into Interlobular ducts---------------------------------pseudostratified cuboidal to columnar epithelium----------many of these join into Intralobar ducts---------------------------------------------------------------------------many of these join into Lobar ducts-------------------------------lined by stratified cuboidal to columnar epithelium.
Merocrine secretion is when cells release their secretions by the normal process of exocytosis. The secretory material of each secretory glandular cell is held inside membrane-bound vesicles inside the cell until the cell is stimulated to release them. When they are stimulated to release their secretion, the vesicles bind to the plasma membrane, the secretion is released into the excretory duct. The membranes of the secretory vesicles then become a part of the plasma membrane, and are not lost. There is no alteration or damage to the cell in the process of merocrine secretion. Examples of merocrine secretion are the sweat glands, salivary glands, and the exocrine pancreas.
Page 11
Holocrine secretion is where the glandular cells themselves become part of the secretion. The secretory cells accumulate the main component of the secretion. The cells then die (whether by the overwhelming accumulation and disruption of metabolic process or a process of apoptosis), and rupture. The secretory product and the cell's cytoplasm is released as part of the secretion. More basally located cells replace the lost cells. Sebaceous glands of the skin use this method of secretion. A way to remember this is holocrine = whole cell dies, like holocaust = whole race dies.
Apocrine secretion involves large parts of the cytoplasm of the glandular cell pinching off and becoming the secretory product, a bit like holocrine secretion, but not the whole cell. The secretory product is stored in the glandular cell near the luminal surface. When stimulated to secrete, that region of the cytoplasm is isolated by the plasma membrane and released into the duct system, much like a giant vesicle. Classification of apocrine secretion is somewhat controversial. Many glands previously identified as apocrine are now, with developments of EM, classified as merocrine. The important example is the mammary glands, that produce milk, and in particular, the fats involved in milk. This makes sense because it most likely involves a fat-based secretory product that is not membrane bound, and therefore cannot pass through the plasma membrane in normal exocytosis.
Page 12
The three major salivary glands are: Parotid gland - entirely SEROUS (100%) Submandibular gland - mostly SEROUS, some MUCOUS (80/20%) Sublingual gland - mostly MUCOUS, some SEROUS (80/20%)
A mucous-secreting cell (which you should not confuse with a mucous secreting goblet cell) has a flattened, peripherally-located nucleus and mucin granules that stain very lightly under H&E. This sort of secretion is viscous, sticky, and high in carbohydrates.
A serous-secreting cell has a rounder, centrally-located nucleus, and a cytoplasm that contains typical protein-synthesising organelles. They therefore stain well under H&E. The secretion is thin, watery, and high in proteins (usually enzymes). When a gland is mucoserous, the arrangement is usually of note. Under histological preparation, certain things happen that push the serous-secreting cells to the edge of the acinus, resulting in what we call serous demilunes.
Page 13
Endocrine glands:
Endocrine glands do not have ducts. Their secretions diffuse directly into the surrounding connective tissue and bloodstream within. Their secretory products are usually hormones, whose action is usually effective far away from its point of secretion. Example: the pituitary gland is located inferior to the hypothalamus and produces hormones that affect many parts of the body far from its location.
Pancreas:
The pancreas is interesting because it is a mixed gland, which means it is both endocrine and exocrine. In this case, the exocrine and endocrine secreting cells are different cells that are found in different compartments within the gland. A group of exocrine cells secreting into a common duct, is, as we know, an acinus. The exocrine portion of the pancreas is considered either a compound acinar or compound tubuloacinar gland. The main secretions of the pancreas leave the pancreas by one or two major excretory ducts and are released into the duodenum of the small intestine. The endocrine portion of the pancreas form small island clusters of cells, known as the Islets of Langerhans. They have many capillaries associated within them so that their hormones (e.g. insulin, glucagon) can enter the bloodstream.
2. You should also review the diagrams depicting the types of DUCTS for exocrine glands. A good one is in Kierszenbaum p59 (2nd edition)
Page 15
Connective Tissue
Fibroblasts
Page 16
Fibroblasts have different names that depend on the location and type of tissue they are present in. For example, a fibrocyte is present in fibrous tissue (like loose connective tissue), an osteocyte is a mature cell present in bone, a chondrocyte is the main cell in cartilage, and an adipocyte is a fat cell. We also need to make clear the difference between -blast and -cyte cells. The suffix "blast" usually refers to an immature cell that is actively producing the connective tissue component (that is, the extracellular matrix), whereas the "cyte" is referring to the mature cell that is just maintaining the tissue. For example, a fibroBLAST is acively producing and secreting colagen fibres and ground substance, and an osteoBLAST is actively synthesising and secreting the bone matric (osteoid). An osteoCYTE will be the mature form of the osteoBLAST, will be less active, and will be maintaining the secretion. The cells of connective tissue are widely scattered, separated from each other by extracellular matrix. Few, if any, cell junctions exist between the cells of connective tissue. Very important to remember: The cells produce the extracellular matrix! Also very important: many other cell types may be foound in connective tissue, that is, they make use of the connective tissue properties to "do their own thing".
Extracellular Matrix
Extracellular matrix (ECM) is composed of (amorphous) ground substance and fibres. Amorphous ground substance consists of: GAGs (glycosaminoglycans) Hyaluronic acid Proteoglycans These substances form a hydrated gel in which the cells and fibres are found. Fibres include: Collagen fibres (including reticular fibres) Elastic fibres Always remember: ground substance and fibres are secretions of the connective tissue cells (fibroblasts, chondroblasts, osteoblasts, adipoblasts).
Glycosaminoglycans:
Page 17
There are four groups of glycosaminoglycans. Glycosaminoglycan 1. Hyaluronic acid Sulation? no Protein linked? no Distribution synovial fluid, skin, support tissue cartilage, bone, skin, support tissue skin, blood vessels, heart BM, lung arteries lung, liver, skin, mast cell granules cartilage, cornea, vertebral disc
4. Keratan sulphate
yes
yes
The sulphation is important. Sulphation causes the groups to be highly negatively charged, which contributes to their ability to retain sodium ions and water. All of the glycosaminoglycans are bound to a protein to form a proteoglycan (except hyaluronic acid). This aggregate is described on p119 of Kierszenbaum, for clarification.
Glycosaminoglycans remain expanded and therefore occupy an enormous volume for a small mass. This forms a flexible gel through which metabolites can diffuse easily.
Page 18
Fibres:
Collagen
Collagen is the principle fibre in the ECM. It is the most abundant fibre found in the body. Approximately 19-21 different types of collagen have been described, and up to 27 identified. Each type of collagen has a different 3-dimensional structure which confers different properties. (Recall that with proteins, it is the three-dimensional structure that defines its function). Type I: Type II: Type III: Type IV: Type VII: The most common form of collagen Cartilage Reticulin (more often referred to as reticular fibres) Basal lamina Anchoring filaments in BM
Page 19
Each collagen molecule is three proteins woven together. This gives collagen its great tensile strength. Under electron microscopy, they are arranged as 67-68 nm-thick bands, and can sometimes be confused with skeletal muscle because of its striated appearance. You would rarely, if ever, be asked to differentiate between skeletal muscle and dense regular connective tissue, and if you are, it would be stained in a particular way to make it quite obvious. The above picture contains both collagen and elastic fibres - make sure you learn which are which because it's a good prac exam question. Reticular fibres (type III collagen) These fibres are found at the boundary between epithelium and its underlying loose connective tissue. Reticular fibres also surround adipocytes, small blood vessels, nerves, and muscle. See below section of the liver, stained particularly to highlight the presence of reticular fibres.
Reticulin is an early form of connective tissue and is often later replaced by type I collagen. It forms scar tissue in wound healing, but because type I has greater tensile strength, is usually replaces reticular fibres. Reticular fibres also function as supporting stroma for haemopoietic (blood-forming) tissue and lymphatic tissue. It is produced by reticular cells. Elastic fibres A good exam question is to identify an organ or structure based on the presence of a big black band of something. You can pretty much straight away guess that this black band is the presence of elastic fibres! But ONLY under a certain stain called ORCIEN STAIN. These are the second type of fibres found in ECM. They are made of the protein elastin, and require the presence of a fibril-forming glycoprotein called fibrillin. Characteristically, elastic fibres are useful for places that require stretch, because they do not lose their structure when stretched. Additionally, elastic fibres are able to provide a tissue with a feature called elastic recoil, which is where the tissue will passively return to normal structure after stretching.
Page 20
In tissues, elastic fibres can be present both as individual fibres (both straight and branching),or as sheets of unidirectional elastic fibres called elastic lamina. The key example of an elastic lamina is the aorta, which requires elastic recoil after being forcefully filled with blood from the left ventricle of the heart. See below picture of a muscular artery, note the presence of both an internal elastic lamina (close to the lumen of the vessel), and an external elastic lamina (after the middle muscular component).
Structurally, it resembles loose connective tissue. It has a semi-fluid ground substance. It develops from mesoderm (the middle embryonic disc). It is the precursor for virtually all connective tissues.
Notice in the above picture, the loose connective tissue underlying the epithelium. (Yes this section is a bit funny, don't worry about it). Loose, or areolar, connective tissue is the most common form of connective tissue. It is found beneath every epithelium. The reason for this is that epithelium is avascular, and requires nutrients, and loose connective tissue's properties provide for the diffusion of nutrients to overlying epithelium.
4. Mast cells (these secrete histamine as a part of the immune response) 5. Undifferentiated mesenchymal cells (these are basically stem cells; they could differentiate into some of the above cells.
Dense irregular connective tissue is characterised by collagen bundles arranged in many different directions. The primary example of this tissue is the reticular layer of the dermis. The nature of the collagen bundle arrangement allows the tissue to withstand moderate forces from many different directions. This is its primary function.
Dense regular connective tissue is characterised by bundles of collaged arranged in a parallel fashion. It is found only in tendons, ligaments and aponeuroses (membranes separating muscle from each other). This parallel arrangement provides the tissue with the ability to withstand and transmit (i.e. to bone) great unidirectional forces. Smooth muscle tends to look similar to dense regular connective tissue in a histological section. To tell them apart, remember that smooth muscle would never appear by itself (i.e. it would appear in association with something like a visceral organ or a blood vessel), where as dense regular connective tissue could appear as a tendon or ligament by itself (in almost all cases). Also, the nuclei of myocytes in smooth muscle tissue tends to look like a Twistie, whereas the fibrocytes of dense irregular connective tissue will look elongated and flattened, and parallel to the direction of the fibres. Very little ground substance exists.
requirement. Elastin can be broken down over time (like in the skin, where it is accelerated by prolonged exposure to UV light, hence the appearance of wrinkles). Always remember that where there is an elastic lamina, it would also include collagen fibres and bundles. Elastic fibres are stained black under Orcien stain. Elastic connective tissue is an important component of the heart's ability to maintain pressure, even when the ventricle is relaxed. That is, the pressure inside the aorta during diastole is usually about 80 mmHg, even though the ventricle is relaxed. It is the effect of the elastic lamina that encourages recoil of the aortic wall.
Adipose tissue:
Adipose tissue is a form of special connective tissue. Make sure you do not confuse adipose tissue for mucous acini. The nuclei of adipocytes will be much smaller than mucous secreting cells, and mucous secreting cells will have some serous secreting cells associated with them too (which are easier to identify).
Also known as multilocular adipose tissue. It has many small lipid droplets in its cytoplasm instead of one large one. It contains many mitochondria which give it an eosinophilic appearance under histological section. It will also appear foamy. Its main function is to metabolise fat to produce heat for neonatal babies. It usually is only present in babies, but it may be present in adults at selected sites (although this is disputed).
Cartilage:
Cartilage is also a special connective tissue. Why? It has a supporting and protective role as part of the musculoskeletal system. Cells are widely spaced and separated by extracellular matrix (ground substance and fibres!) Variations in the extracellular matrix indicates different types of cartilage tissue Embryological origin from mesenchyme (and therefore mesoderm) Cartilage formation is a precursor to bone formation in both endochondral and membranous ossification. Some key terms to know when talking about cartilage: Cells of cartilage: chondroblasts and chondrocytes Lacuna: this is the space within which the condroblasts and chondrocytes sit. "Lacuna" means "little lake". Matrix: the extracellular matrix of the cartilage. This makes up 95% of cartilage by volume. It contains lots of GAGs. Perichondrium: the connective tissue covering of cartilage. Remember that almost all cartilage is avascular, so it needs a connective tissue coating for its nutrition.
Page 26
There are three types of cartilage Hyaline cartilage: E.g. trachea, lining the surface of joints, no perichondrium Predominance of Type II collagen Is the skeleton in the fetus Elastic cartilage: 1. E.g. epiglottis, parts of the ear, the auditory tube, a small amount in the nose. 2. Dead giveaway when stained by Orcien Fibrocartilage: This is an intermediary between dense regular connective tissue and cartilage. You might like to think of it as tough, tendinous cartilage. Exists between the vertibrae, where you don't want much movement. Has great strength Cartilage is covered in greater detail in CAM102.
Bone:
Bone is also a special connective tissue, because it has cells (osteoblasts and osteocytes) embedded in an extracellular matrix, secreted by the cells themselves. The major difference is that the ECM has become mineralised with calcium salts. There are two forms of bone in the adult human: Compact bone Cancellous (or trabecular or spongy bone) Bone is covered in greater detail in CAM102.
Page 27
Red blood cells lack a nuclei. They appear slightly eosinophilic (because of the protein content of their cytoplasm). Leukocytes White blood cells. There are five types, divided into "granular" or "agranular". Lymphocyte
An agranular leukocyte. Most lymphocytes are small and not much larger than a RBC. They have a round, densely stained nucleus and only a little amount of pale, basophilic, agranular cytoplasm. Larger lymphocyts have both more cytoplasm and a larger, paler nucleus. You'll remember from Dr Woods' lectures that there are B and T lymphocytes, and that some lymphocytes differentiate into plasma cells. If this happens, you would expect their cytoplasm to grow to accommodate the enlargement of organelles that are required for rapid protein (immunoglobulin) synthesis. Monocytes
These are the largest of the leukocytes. Monocytes are agranular, and they are the cells that differentiate into macrophages once they leave the bloodstream and enter the surrounding tissues. They have a large nucleus, stained less intensely than other leukocytes, and is usually indented (horseshoe shaped). Neutrophil
Page 28
Granular leukocyte. Called neutrophils because they are neither heavily basophilic or heavily eosinophilic. Also known as a polymorphonuclear leukocytes because their nucleus is composed of several lobes connected to each other by fine strands. The cytoplasm is packed with many fine, "peppery" granules. The balance of staining will make the colour and visability of the granules differ a lot in different slides. Eosinophils
These are granular. They are the most easily identifiable leukocytes because of their large, (usually) orangered cytoplasmic granules. The nucleus may be obscured by the granules but are usually bi-lobar. Basophils
These granular leukocytes are the hardest to find. The large, deeply-staining blue-black cytoplasmic granules may obscure the simple or bi-lobed nucleus. The granules are water soluble and may therefore dissolve during histological processing.
Page 29
Muscle Tissue
Muscle tissue is one of the four adult tissue types. There are three types of muscle: cardiac, skeletal, and smooth. All three types of muscle are composed of elongated cells that have many names that all mean the one thing: myocyte, myofibres, muscle fibres. In all three types of mucle, energy from the splitting of ATP is transferred into mechanical energy that results in movement. We should note here that there are other types of contractile cells in the body: Myoepithelial cells - you will recall that these are associated with exocrine glands, and they contract to help propel the secretion into and through the duct. A good example is the eccrine sweat gland. They are contractile cells of epithelial tissue. Myofibroblast cells - these cells are normally associated with repairing tissue, but can also be associated with other tissues such as in the interstitial tissue of the testis. They are the contractile cells of connective tissue. Pericytes - these cells surround endothelial (inner lining of blood vessels) cells beneath the basal lamina. They are sometimes considered myofibroblast. Their contraction causes a decrease in the size of the lumen of capillaries.
The three types of muscle can be easily classified by a couple of distinguishing features: Microscopic appearance: Striated Skeletal and cardiac Non-striated Smooth Innervation: Voluntary Skeletal
Page 30
Involuntary
Skeletal muscle:
Skeletal muscle develops from cells called myoblasts, which fuse to form large multinucleated cell. That is, myoblast + myoblast + myoblast = 1 large, multinucleated myocyte. (A muscle cell). It is for this reason that skeletal muscle is referred to as a true syncitium. A key part of distinguishing skeletal muscle from smooth and cardiac muscle is that the nuclei are located at the periphery of the cell in skeletal muscle. So if you see a cross-section of muscle, and the nuclei are at the edge of each cell, you know it is skeletal muscle. There is a lot of annoying, complicated terminology used for skeletal muscle tissue, and it is just best to sit down and learn it now. To make it easier, you can try and visualise the terms from getting bigger to smaller. A muscle, e.g. your biceps brachii, is composed of bundles of muscle cells called fascicles. Each fascicle is composed of many muscle cells that span the length of the muscle. Intracellularly, there are many groups of cytoskeletal contractile proteins called myofibrils. These are bundles cytoskeletal microfilaments named myofilaments. They are arranged in a particular pattern to give a striated appearance to skeletal muscle. There are two types of myofilaments: thick and thin. Thick are composed primarily of myosin, and thin are composed primarily of actin. (To remember this, just remember actin has less letters and is therefore thinner than myosin). Aside from these terms related specifically to muscle tissue, there are terms about the surrounding connective tissue of a muscle cell that we need to learn. The connective tissue surrounding a muscle is what enables the muscle to transfer its force to bone so that movement can occur. There are three connective tissue capsules: epimysium, perimysium, and endomysium. They are primarily composed of a dense arrangement of collagen fibres. Within these connective tissue components lies blood vessels, nerve fibres and lymphatics. Epimysium surrounds the entire muscle, for example, it would surround your entire biceps brachii. Perimysium exists around, and in between, fascicles. Endomysium lies around each muscle cell (which, remember, spans the entire length of the muscle). Actin and myosin are also important to understand on a microscopic scale. They are both proteins, and form components of thin and thick filaments.
Page 31
Thin filaments are: 7nm in diameter and 1 micron in length Each thin filaments is 2 strands of filamentous actin arranged in a double helix formation Also contain the proteins troponin, tropomyosin and nebulin. Thick filaments are: 15nm in diameter and 1.5 microns in length Arranged like two golf clubs with intertwined shafts, with the golf club heads pointing in opposite directions. Each myosin head (the golf club head) has an actin-binding-site, and an ATP-ase, that is an enzyme that breaks down ATP. Thick filaments also contain titin (easy to remember because it is a big, big protein). The thick and thin filaments are arranged together in a particular formation that allows contraction by a mechanism called the sliding-filament mechanism. This will be covered next semester so we won't worry about it here. But, we need to know that the functional unit of skeletal (and cardiac) muscle is the sarcomere, which is a portion of the muscle that looks like this next picture.
A muscle cell will have thousands of these sarcomeres running along its cytoplasm. When they are stimulated to contract, the thin and thick filaments slide over each other and they basically get smaller, reducing the length of the whole cell and creating contraction. Don't worry about the mechanism too much, just know what it looks like and be able to identify it if it comes up in the practical exam.
Page 32
Also within a skeletal muscle myocyte, you should be aware of the sarcoplasmic reticulum. It is a reticulum much like smooth endoplasmic reticulum, and holds lots of things, but especially calcium, which is essential for the contraction mechanism. To recap this section: Actin and myosin - are cytoskeletal microfilamentous proteins that form components of thin and thick filaments Thin and thick filaments
The above picture is skeletal muscle. Note the peripherally-located nuclei in each muscle cell, the endomysium connective tissue surrounding each muscle cell, the perimysium connective tissue surrounding and dividing up the fascicle. The epimysium cannot be seen, because as you know, it surrounds the whole muscle. This next picture puts it into a little more perspective. Test yourself and see if you can name what sort of tissue each component is. (I didn't mention this before, but the plasma membrane of a muscle cell is also referred to as the sarcolemma).
Cardiac muscle:
Page 33
Cardiac muscle, like all other muscle, is derived embryonically from mesoderm. It is found only in the heart, and in portions of the large arteries closer in the heart. A cardiac cell, known as a cardiocyte, has a diameter of 15 microns and a length of 80 microns. (Note that what is says in Kierszenbaum is incorrect here). Like skeletal muscle, it is striated. But unlike skeletal muscle, cardiocytes are branching. See the diagram back at the start of the section on muscle, and the one directly above. Each cardiocyte junctions with a couple of other cardiocytes. Other important features of cardiac muscle include: cardiocytes have a centrally placed nucleus (useful for distinguishing between cardiac muscle and skeletal muscle) cells joined by specialised junctions called intercalated discs innervated by the autonomic nervous system inherent rhythmicity (that is, will contract without nervous system stimulation) mitochondria make up 50% of the volume of the cell (hence the eosinophilia of cardiocytes in histological section) calcium is supplied from outside the cell (important for contraction)
Intercalated discs are exclusive to cardiac muscle. They are junctions located between cardiocytes. They are a step-like arrangement that include vertical and horizontal components. The transverse component is located at the z-line of the sarcomere in adjacent cardiocytes (A in the diagram). Here, both fascia adherens and desmosomes hold the cells together (B in the diagram). Also associated closely are gap (communicating) junctions (C in the diagram). The gap junctions in cardiac muscle are extremely important and it is really important to understand why cardiocytes are referred to as a functional syncitium. Unlike skeletal muscle, which is a true syncitium and composed of aggregates of precursor cells in one big cell, each cardiocyte is a cell by itself. Because of the gap junctions, they are able to very quickly transmit a chemical signal, first originating in a cell that has a connection to a nerve, to thousands of other cardiocytes by the passage of ions. This allows the cardiocytes to contract at the same time. Hence, they are not a structural syncitium, because they are separate cells, but they are a functional syncitium.
Smooth Muscle:
Page 34
Smooth muscle is found as part of most organs that have a hollow component (the gastrointestinal tract, the bladder, the ureters, for example) and in blood vessels. It is innervated by the autonomic nervous system, like cardiac muscle, and is therefore involuntary. Cells are attached to each other via gap junctions and a basal lamina. Unlike sketal muscle, which has highly organised arrangement of actin and myosin microfilaments, smooth muscle has a random arrangement of actin to densities on the cell membrane called dense bodies or focal densities. See picture below. The cells communicate to each other via gap junctions.
At the EM level, numerous pinocytotic vesicles are characteristic of the cell membrane. They also have a centrally-located nucleus, like cardiocytes, and unlike skeletal muscle fibres.
Page 35
Nervous Tissue
Organisation of nervous tissue:
This semester is only a very, very brief taste of the nervous system. We'll cover it in a lot more detail in other units. It's my favourite system so I hope they do it justice. Nervous tissue can be organised broadly into one of two locations: the Central Nervous System (CNS) and the Peripheral Nervous System (PNS). The CNS is quite simply the brain and the spinal cord. The PNS is composed of cranial nerves (twelve of them), spinal nerves, and ganglia. The PNS has two components: Sensory afferent (afferent = towards) Motor efferent (efferent = away from) The MOTOR EFFERENT component is further divided into: The Somatic Nervous System (SNS) The Autonomic Nervous System That is, both the SNS and ANS are motor systems. The ANS is further divided into: 1. Sympathetic Nervous System (the system that controls the "fight, flight and frolic" responses in most cases) 2. Parasympathetic Nervous System (the system that controls the "rest and digest" responses in most cases)
Neurons have the special ability to transmit a signal (known as an action potential) along a cell surface by reversing the polarity of the cell membrane. Highly specialised contact points known as synapses exist between neurons and allow this signal to pass from cell to cell.
Page 36
Neurons:
Some key properties of a neuron: 1. Cell body, also called the soma or perikaryon 2. Nissl bodies in cytoplasm - large accumulations of rough endoplasmic reticulum and lots of free ribosomes 3. Axon hillock - the point at which the axon and the soma are connected; where the action potential begins 4. Dendrites - branch-like process extending from the cell body 5. Axon - a bigger, thicker dendrite 6. Myelin sheath - wrappings of the plasma membrane of glial cells around the axon 7. Nodes of Ranvier - the gaps between the wrappings of plasma membranes of glial cells around the axon 8. Axon terminals - the end of the axon, where the synapse occurs 9. Synaptic end-bulbs - branches of the axon that bulb at the end to carry an action potential to multiple cells 10. Synapses - where the action potential is transferred to another cell; can be from axon to axon (axoaxonic), from axon to soma (axo-somatic) or axon to dendrite (axo-dendritic). Neurons are put into broad categories based on their structure: Pseudounipolar neurons
Page 37
Bipolar neurons, and multipolar neurons. There are other classifications. See diagram.
Synapses:
Synapses are communication points between neurons and other neurons, or, the effector cells such as muscle cells in the neuromuscular junction. Synapses have several important features from a histological viewpoint: 1. Presynaptic end bulb (terminating bouton) containing: 1. Synaptic vesicles containing neurotransmitter 2. Presynaptic plasma membrane thickening 2. Synaptic cleft (basically a space) 1. Postsynaptic plasma membrane thickening 2. Ligand-gated (neurotransmitter receptors) ion channels (not visible in histological section)
Myelination of axons:
Page 38
Oligodendrocytes produce myelin in the CNS. Schwann cells produce myelin in the PNS. Myelin is a wrapping of portions of the axon by the cell membrane of a glial cell (Schwann or oligodendrocyte).
As the myelin sheath is composed of plasma membranes, they will appear differently under light and electron microscopes. Under the LM, lipids are usually removed through processing and so myelinated axons in cross-section appear as pink rings of predominantly white empty spaces with a small eosinophilic dot in the centre (representing the axon). This is important! It featured in our formative practical exam and will probably come up again in our next one! Under EM, the myelin sheath will appear as concentric electron-dense rings (big and black!) around axons. There are critical differences in the myelination by Schwann cells and oligodendrocytes. Oligodendrocytes send out long processes that wrap around the axons of neurons to form the myelin sheaths, and so each oligodendrocyte can myelinate a number of axons, or more than one site on a single axon Schwann cells are closely associated with the axons they myelinate, and a Schwann cell only myelinate one part of a single axon. So an axon that can be up to two metres long (suppling your toe for example) may have thousands of Schwann cells associated with it. Other key histological features differ between the CNS and the PNS: Nodes of ranvier (the spaces between adjacent myelin sheaths) in the CNS are covered by the
Page 39
processes of a type of CNS glial cell called the astrocyte. In the PNS, the nodes are covered by extensions of the Schwann cell cytoplasm. The Schwann cell also has an external lamina external to it; this is not present in the CNS.
Not every axon has myelination! In the CNS, non-myelinated axons are structurally supported by surrounding non-oligodendrocyte cells (mostly astrocytes). In the PNS, however, non-myelinated axons are still closely associated with Schwann cells, and become embedded in the cytoplasm of the Schwann cell, without being myelinated by it. See the bottom-right part of the diagram above (the part that says 5). Several axons may associate with one Schwann cell in this non-myelinated manner.
Peripheral Nerves:
So, what actually makes up a peripheral nerve that we are going to come across in our practicals? Peripheral nerves contain: 5. Axons (both myelinated and unmyelinated) 6. Schwann cells (associated with nerve fibres) 7. Fibroblasts/cytes (associated with the following connective tissue layers) 8. Endoneurium (loose connective tissue surrounding individual axons and the Schwann cells) 9. Perineurium (denser connective tissue surrounding bundles of axons known as fascicles) 10. Epineurium (dense connective tissue surrounding the entire peripheral nerve) 11. Jamie forgets to mention here that there will be blood vessels and lymphatics in the nerve also Do those connective tissue layers sound familiar? They should. Remember the connective tissue layers of skeletal muscles? Kierszenbaum has a pretty good diagram that sets it out well:
Page 40
Notice that in the peripheral nerve there are no nuclei of neurons. If you're looking at a peripheral nerve and see nuclei, you're probably seeing a Schwann cell or a fibroblast (or another cell associated with the connective tissue component, although this is less likely). Don't make the mistake of saying there are cell bodies of neurons! This would only occur in ganglia.
Ganglia:
A ganglion is a collection of neuronal cell bodies (somas) located outside the CNS. All ganglia are part of either the sensory (afferent) nervous system, or the ANS. They could be either: Dorsal root ganglia (sensory) Found just outside the spinal cord; contains ONLY sensory neurons Sympathetic ganglia (motor) Found predominantly in a long chain running parallel to the vertebral column but also in several sites associated with the major blood vessels of the abdominal organs Parasympathetic ganglia (motor) Found intramurally (within the wall of the organ/tissue they supply) This will all be covered in much more depth, including how to find a ganglion in a histological slide, in CAM102.
Page 41
Epidermis
An avascular layer of stratified keratinised epithelium sitting on a basement membrane. (Recall that a basement membrane is made up of a basal lamina and a reticular lamina) The epithelium can be subdivided into 4-5 layers from the base to the free surface: 1. stratum basale (stem cells for skin) (1 layer) 2. stratum spinosum (spiny cells because of lots and lots of desmosomes and shrinkage during histological processing) (4-7 layers) 3. stratum granulosum (lots of granules) (2-3 layers) 4. stratum lucidum (only identifiable in thick skin) (translucent) (a couple of layers) 5. stratum corneum (flattened cells like scales on the surface) (many layers)
Page 42
Keratinocytes
The cells that constitute the layers of the epidermis are called keratinocytes. They appear by division of the cells in stratum basale and move (are pushed) towards the surface by further division of the stem cells in the stratum basale. At the surface of the epithelium, the cells are removed by abrasion. Keratinocytes at the surface are little bags of plasma membrane and keratin. The shape of the cells change as they progress through the layers towards the surface from cuboidal, to irregular spiny, flattened with granules, and then squamous.
Dermal-epidermal junction
Keratinocytes are separated from the underlying connective tissue of the dermis by a basement membrane (remember only stained by PAS) Structural integrity of the dermal-epidermal junction is maintained by: o tethering fibres o highly folded membranes o rete ridges or epidermal pegs particularly found in thick skin
Cells are in constant contact with each other by a system of intercellular bridges held together by desmosomes Cells contain many tonofilaments
Lifespan of a keratinocyte
Turnover from basal cell to keratin layer varies: o 25-30 days in areas with lots of friction (e.g. soles of feet, palms of hand) o 40-50 days in areas of less friction This turnover period is considerably shortened in some disease states (e.g. psoriasis)
Soft keratin stratum corneum (and lucidum) Hard keratin hair, fingernails, rhinoceros horn
Melanocytes
Melanocytes are dendritic cells that produce melanin and then transfer the melanin to the keratinocytes. They are found in the stratum basale and can associate with as many as 36 keratinocytes. They produce melanin from a base of the amino acid tyrosine and pass it on to the keratinocytes.
Langerhans cells
Dendritic cells of the skin o Found in all cell layers but best identified in the stratum spinosum Form a network within the epidermis Irregularly shaped nucleus No desmosomes or melanosomes (to facilitate easy movement) Contain distinctive granules (Birbeck) visible with the electron microscope
Page 44
o They look like racquet handles, only visible under EM, play a role in breaking down the antigen Function as antigen presenting cells o Important component of the immune system Paler nucleus than the surrounding keratinocytes
Merkel cells
Located in the basal layer of the epidermis Always associated with the end of a sensory neuron (nerve cell) Part of the sensory reception mechanisms of the skin Respond to touch Granules in the cytoplasm that have a neurotransmitter-like action with the sensory nerve ending
Types of skin
Thick or glaborous (hairless) sole of the feet and palms of the hand also called friction skin deep folds on the basal surface of the epidermis (fingerprints) to better attach the epidermis to the dermis Thin (hairy) covers the rest of the body nearly all thin skin has hairs some hairs are not obvious to the naked eye The main difference structurally between thick and thin skin is in the stratum corneum. The other layers (the living layers) are very similar.
Dermis
Layer of irregular connective tissue underlying the epidermis o both loose and dense irregular connective tissue o it supports the epidermis and gives great strength and flexibility to the skin 1. It contains many of the accessory structures of the skin, such as: o hair follicles o nerve fibres and sensory receptors o sebaceous glands o sweat glands o blood and lymphatic vessels The dermis can be divided into two region
Page 45
1. Papillary layer immediately below the epidermis forms the dermal papillae between the epidermal pegs a layer of loose connective tissue (areolar connective tissue remember every epithelium has an underlying layer of loose connective tissue 2. Reticular layer between the papillary layer and the hypodermis the true dermis and is a dense irregular connective tissue
Hypodermis
Below the dermis is the hypodermis (superficial fascia) largely a layer of adipose tissue and areolar connective tissue Often considered to be part of the integumentary system Sometimes the bottom of hair follicles can be seen extending into the hypodermis.
Encapsulated sensory receptors Meissners corpuscles are located in the dermal papillae of the dermis. They respond to light tough Pacinian corpuscles are large onion-like structures deep in the dermis. They respond to deep pressure and vibrations. Free nerve endings These are not encapsulated receptors They respond to heat, pain, cold etc. Many work via their attachment to the hair bulb; movement or touch from the hair is recognised by the nerve endings Some actually penetrate between the cells of the epidermis.
Hair follicles
Hair follicles are down growths of the epidermis We will see the same layers of the epidermis in the layers of the hair follicle and the hair itself.
Pilosebaceous apparatus
Hair shaft (the part we can see very different from the part below the level of the skin)
Page 46
o cuticle o cortex o medulla Hair bulb the growing point Arrector pili muscle Sebaceous gland
Hair bulb
Contains a specialised area of dermis = hair papilla Lots of nerves and blood vessels Lots of actively-dividing stem cells (matrix) produce the hair shaft and internal root sheath The hair shaft and internal root sheath lie within the external root sheath Melanocytes are found in the hair bulb The internal root sheath contains several layers including the cuticle Cells undergo keratinisation to produce the hair shaft Extends from hair bulb to the level of the sebaceous gland Leaves a space for sebum to be secreted. The external root sheath contains epidermal layers basale, spinosum and granulosum. Surrounded by a thick basement membrane called the glassy membrane.
Hair follicle
All of these layers are surrounded by a fibrocollagenous follicle sheath (FFS), including the sebaceous gland Attached to the FFS is the arrector pili muscle Smooth muscle Attaches at, or just below, the level of the sebaceous gland Upper attachment at papillary dermis Contraction causes hair to stand on end goosebumps
Sebaceous glands 1. Sac-like gland that secretes an oily thick substance called sebum 2. Open onto the skin surface via a hair follicle 3. They are holocrine glands 4. Secretion is viscous and may become secondarily infected by bacteria acne 5. Secretion is controlled by the ANS 6. Activity may be influenced by sex hormones 7. Important lubricant of the epidermis 8. Pyknotic nuclear appearance Sweat glands (eccrine) 1. Simple coiled tubular glands
Page 47
2. Open onto the skin surface via a duct 3. They are merocrine secreting glands 4. The secretory portion of the gland lies deep in the dermis (therefore they have a relatively long duct system) 5. Sweat is a mixture of secretory and excretory products 6. There are different forms of sweating: a. emotional (adrenergic adrenaline sympathetic) b. thermoregulatory (cholinergic Ach parasympathetic) 7. Sweating is controlled by the ANS
Page 48
Each amino acid has an alpha-amino (-NH2) group, and an alpha-carboxylic acid (-COOH) group. These two portions are the same for all the amino acids. The alpha refers to the C-atom to which they are both covalently linked (bound). Each amino acid has a side chain that is unique to that amino acid. It is also covalently bound to the alpha-C-atom. Different amino acids have different side-chains.
Page 49
Proteins
Proteins (or polypeptides) are linear polymers of amino acids. They are polymers consisting of amino acids arranged in a linear sequence (e.g. A-B-C-D) linked by covalent peptide bonds between the alpha-NH2 of one amino acid and the alpha-COOH of the next. Their molecular weight varies from a few thousand to a few million. All proteins contain all of the 20 common amino acids. Each amino acid plays a unique role in protein structure If a specific amino acid is unavailable, it cannot be replaced by another The primary sequence and 3-D structure of the polypeptide must be correct! each protein has a unique sequence (primary structure), and hence a unique three-dimensional structure the three-dimensional structure (usually called secondary or tertiary structure) is maintained by covalent bonds and non-covalent linkages between amino acids Alteration of the three-dimensional structure usually causes loss of function. This can happen if: o non-covalent linkages are disrupted by an increase in temperature DENATURING o covalent peptide bonds between amino acids are split PROTEOLYSIS
Haemoglobin a globular protein that transports oxygen found in red blood cells Actin and myosin responsible for the contraction of muscle tissue
Other significant sources that have high protein content, but because we dont eat a lot of them, arent major dietary sources are : o fish o eggs o nuts o legumes
Dietary proteins provide most of the amino acids for the bodys cells. Proteins cannot be absorbed intact from the gut. Instead, dietary proteins are split by digestive proteolytic enzymes in the stomach and small intestine. The amino acids are then absorbed into the blood and cells where they become available for protein synthesis and other purposes. Some amino acids are made by our cells from non-amino acid precursors; about half of the twenty amino acids can be made by cells from substrates derived from metabolism of such fuels as carbohydrates (discussed later). Amino acids are constantly being incorporated into cellular proteins. Amino acids from dietary protein and amino acids synthesized from non-amino acid precursors all become part of the amino acid pool. Proteins are also constantly being broken down into amino acids in the body. proteins in cells or body fluids have only a short life expectancy, usually only a few days this is because they gradually denature, that is, the non-covalent links between amino acids are disrupted, even at 37oC denatured proteins then get broken down into amino acids by proteolytic enzymes in cells Some amino acids, instead of getting incorporated into proteins, get diverted to other purposes: being catabolized and used for energy (in a low energy state or an amino acid surplus) being converted to glucose (starvation or low-carbohydrate diet) being converted into other specialised low-molecular weight compounds
Meats
Cereals
Legumes
Proteins in diet
Proteolytic enzymes
Taken up by blood
AA POOL
Incorporated into cellular proteins Synthesising new Page 52 proteins for export Diverted for other uses
PROTEIN DEFICIENCY
negative nitrogenPage 53 balance
requires
MORE PROTEIN
for the creation of new cells
Lactation
POSITIVE BALANCE
NITROGEN
Enzymes
Enzymes names almost always end with ase, and often include an indication of the substrate. For example, glycogen synthase participates in the synthesis of glycogen. Each enzyme supports a specific conversion, at its active site. This happens at a special site in the 3-D structure, called the active site. The active site is a cluster of amino acid side-chains, where substrates bind and are modified, and reaction products are released. Each enzyme has a different active site, hence different specificity. The more substrate, the faster reaction: The higher concentrations of a substrate, enzymes work faster. The relationship between reaction velocity and substrate concentration may be the Michaelis-Menten type, or the Allosteric type Michaelis-Menten:
Page 54
Allosteric type:
Coenzymes
Coenzymes are also called cofactors or prosthetic groups. They are essential for many enzymes Many enzymes require coenzymes which are mostly organic Such enzymes cannot operate at all unless the proper coenzyme is attached (covalently for some, non-covalently for others). Many coenzymes are made from water-soluble vitamins Niacin Riboflavin Thiamin Pantothenate Vitamin B6 gives gives gives gives gives NAD+ and NADH, NADP+ and NADPH FAD and FADH2, FMN and FMNH2 TPP Coenzyme A pyridoxal phosphate
Page 55
Folate
gives
Some are used by enzymes that carry out oxidation and reduction reactions in cell metabolism, for example, the following: From vitamin: Niacin Niacin Riboflavin oxidised form NAD+ NADP+ FAD corresponding reduced form NADH NADPH FMNH2
That is, the portion of the vitamin that is the coenzyme will be reduced when helping to catalyse the reaction. X + NAD+ Y + NADH
Inhibitors of enzymes
Some substances can inhibit enzymes. Many enzymes are inhibited by particular chemical substances The inhibitor usually binds to the enzyme reversibly, by non-covalent bonding Some inhibitors, mainly poisons, bind covalently and irreversibly Many drugs act by inhibiting a specific enzymes. For example: o captopril (lowers BP by inhibiting the enzyme ACE) o lovastatin (lowers serum cholesterol by inhibiting the enzyme HMG-CoA reductase) o methotrexate (slows cancer proliferation by inhibiting dihydrofolate reductase) When an inhibitor is used as a drug, we rarely use enough to completely inhibit the enzyme. The aim is to slow itt down. Some inhibitors are competitive They bind to the enzymes active site, and so directly prevent the substrate binding there Many drugs are competitive inhibitors Other inhibitors are non-competitive They bind elsewhere on the enzyme, and indirectly affect the ability of the active site to bind to the substrate Many poisons are non-competitive inhibitors
o Blood is a mizture of formed cells and plasma. While some lab tests focus on components found mainly in blood cells (e.g. haemoglobin), most focus on components found in plasma. o However, when blood is removed from the body, it clots, and this process alters the plasma to become serum (= plasma minus the clot protein fibrin). The clotting can be stopped by adding an anticoagulant to the blood immediately after the collection o The anticoagulant affects the measurement of most enzymes, so only serum is suitable for that
Carbohydrates
Summary facts about carbohydrates: Glucose is the main carbohydrate in the blood It is stored as the polymer glycogen in liver and muscle The central role of glucose is to provide energy for cells (some organs, like the brain, can only use glucose for energy) Fatty acids also have a range of other functions Other important carbohydrates include plant cell wall components (known as dietary fibre) and the glycosaminoglycans of animal connective tissue
Monosaccharides
This is the basic carbohydrate structural unit. Example: hexoses these have 6 carbon atoms example are glucose, galactose and fructose Example: pentoses these have 5 carbon atoms examples are ribose (found in RNA) and deoxyribose (found in DNA)
Disaccharides
These are two monosaccharides linked together by a covalent, glycosidic bond. Example: lactose = galactose + glucose Example: sucrose = glucose + fructose (produced by sugar cane and other plants)
Polysaccharides
These are carbohydrate polymers (many monosaccharides). They are also called glycans or complex carbohydrates. Some are linear (that is, unbranched) polymers, others are branched polymers. Some consist of only glucose molecules linked together, others have more than one monosaccharide component. Examples: Glycogen (polymers of glucose; made in the liver and muscle for storage) Amylose and amylopectin (starches) Dietary fibre Glycosaminoglycans
Page 57
Glucose (blood)
STAYS IN MUSCLE
amino acids
triglyceride breakdown
Surplus glucose can be converted to other substances for various purposes Glycogen (in liver and muscle) o mainly happens a few hours after a meal, when blood glucose levels are high Fatty acids and amino acids o mainly happens a few hours after a meal, mainly in the liver o inly a limited range of amino acids can be made from glucose o conversion of glucose into fatty acids and amino acids is fairly limited in humans Liver glycogen is used to top up plasma glucose levels. Normally, there is only limited fluctuations of blood glucose and cellular glycogen levels.
Starches
Amylopectin, amylose. Both amylopectin and amylose contain glucose as their only monosaccharide component. Amylopectin is branched (similar structure to glycogen, though branch-points are less frequent) Amylose is unbranched They are found in foods of plant origin, notably cereal, grains, potatoes, and legumes (e.g. soybeans, chickpeas) Amylopectin usually comprises the majority of the starch
Dietary fibre
This is a collective term used for several polysaccharides found in plant cell walls Their importance for humans and animals is increasingly being recognised One major type is cellulose Our major dietary sources are cereal grains (especially wholemeal and wholegrain), fruits and vegetables. They cannot be digested by enzymes that animals and humans produce, although, the bacteria that normally live in the gut can ferment them. They prevent constipation, probably helping to contribute to gut health in other ways too.
Glycosaminoglycans
These are unbranched polysaccharides that contain amino-sugar monosaccharides (e.g. glucosamine), generally with more than one monosaccharide component. For example: o Condroitin sulphate an important structural component of cartilage o Hyalouronate an important structural component of joints
Carbohydrates in diagnosis
Plasma (or blood) levels are often measured in human patients. High levels often indicate diabetes mellitus.
Page 60
Lipid (fats)
Triglycerides are the most common lipid found in the body, where they are used as an energy store. They are made of fatty acids attached to glycerol. Apart from being an energy store, fatty acids have a range of other functions. Other important lipid (present in much smaller amounts in the body) include cholesterol, phospholipids, fat-soluble vitamins and eicosanoids. Each of these have important functions.
Saturated fatty acids Have no double C=C bonds in the aliphatic chain Examples include: o palmitate C16:0 o stearate C18:0 o The 16 and 18 refer to how many Cs there are, the zeros refer to how many C=C double bonds there are in the molecule Monounsaturated fatty acids (MUFA)
Page 61
Polyunsaturated fatty acids (PUFA) Have more than one C=C double bond In polyunsaturated fatty acids, double bonds are three C-atoms apart o i.e. C=C-C-C=C-C-C=C-C-C=C-C-C=C-C-C=C-C-C o It is important biologically to distinguish 3 and 6 polyunsaturated fatty acids Omega 3 (3) polyunsaturated fatty acids First double bond begins with the third C-atom from the end. These examples are important and must be memorised: o ALA alpha-linoleate, C18:3, 3 o EDA C20:5, 3 o DHA C22:6, 3 Omega 6 (6) polyunsaturated fatty acids First double bond begins with the sixth C-atom from the end. These examples are important and must be memorised: o linoleate C18:2, 6 o arachidonate C20:4, 6 Note linoleate is C18:2, 6, and alpha-linolenate is C18:3, 3
Increase the risk of cardiovascular disease: saturated fatty acids trans monounsaturated fatty acids trans polyunsaturated fatty acids Decrease the risk of cardiovascular disease: cis monounsaturated fatty acids cis polyunsaturated fatty acids (3 and 6) So, to prevent or treat cardiovascular disease, it is is helpful to modify the fatty acid composition of our diet. Nervous tissue alpha-linolenate (C18:3 3) polyunsaturated fatty acid is important for normal development of the retina and synapses Skin linolenat (C18:2 6) polyunsaturated fatty acid is important for normal development of the skin.
Fatty acids catabolized to release energy, Some may be catabolized to provide energy, some may be diverted to other specialised functions (such as ketone body formation) Ketone bodies are mainly formed during starvation as an auxiliary energy source for muscles
Some fatty acids can be made in our cells, others are essential In practice, much of the fatty acids in our body come from dietary triglycerides Saturated and cis-monounsaturated fatty acids are non-essential (we can make these from carbohydrates) o We dont actually need these fatty acids in our diet, through in practice most of these in our cells come from our diet Note, we cannot convert fatty acids into carbohydrates o However, plants can Two C-18 polyunsaturated fatty acids are essential in our diet and cannot be made in our cells: 1. alpha-linolenate C18:3 3 2. linoleate C18:2 6 Plants and bacteria can make these fatty acids. Other fatty acids are conditionally essential, that is, can be made in our cells under certain circumstances. We can make limited amounts of them from other substances found in our cells, but when demand is heavy, we cant make enough of them. They include: o longer 3 polyunsaturated fatty acids (C:20 and C:22) o longer 6 polyunsaturated fatty acids (C:20 and C:22) For example, to make C:20 3 PUFA, we can convert C:18 3 C:20 3 or, to make C:22 6 PUFA, we can convert C:18 6 C:20 6 C:22 6.
Specialised lipids
Eicosanoids
Examples are thromboxanes and prostacyclins These are local hormones made in the body from polyunsaturated fatty acids They are not present in foods Different eicosanoids affect blood clotting, blood pressure and inflammation
Phospholipids
Structurally similar to triglycerides, but also contain phosphate and organic bases (e.g. chlorine) Crucial in cell membrane, breathing, blood clotting Small amounts are in some food, but these get digested in the gut We make them in our cells, so they are not essential in our diet
Page 64
FA
Absorbed into enterocytes and
FA
CIRCULATION
storage in some
FA
usage
Adipocytes
TG catabolized (constant)
Page 65
Micronutrients
Summary: Micronutrients are low-molecular weight components that carry out specialised infrastructure functions in the cell Almost all substances in this category (there are a few exceptions) cannot be made in the body They are not catabolized to produce energy (although some play a crucial role in obtaining energy from our major energy sources) We only need small amounts of them (most: a few milligrams, some even a few micrograms or nanograms per day) The difference between vitamins and minerals is that o Vitamins are organic o Minerals are inorganic
Proper bone structure: Vitamin C for proper collagen structure Vitamin D for maintaining blood calcium (bone resorption)
Iron (Fe) essential for making haemoglobin deficiency anemia Calcium (Ca) essential for bone and teeth structure important for signalling inside cells and for muscle contraction deficiency rickets, osteoporosis Sodium (Na) important for neuronal impulses; affects plasma volume excess high blood pressure (restriction of dietary Na reduces the risk of high blood pressure) Iodine (I) essential for making thyroid hormones (thyroxine etc.) deficiency formation of thyroid goitre, retarded growth, cretinism Selenium (Se) essential part of several key enzymes deficiency damage to heart muscle, may increase the risk of CVD and cancers excess toxicity
Page 67
A Healthy Diet
Summary: The National Health and Medical Research Council is the peak health advisory body to the Australian federal and state government NHMRC issues diet advice in two major forms: 1. Nutrient Reference Values (expressed in terms of quantitative nutrient intakes) 2. Dietary guidelines (expressed as qualitative statements about some nutrients and some food practices) Also, the Federal Health Department has released The Australian Guide to Health Eating, which seeks to translate the above into practical statements about food choices
EAR, RDI and AI indicate the quantity of a nutrient we need to avoid deficiency. For a given age-gender group: EAR estimated average requirement o is the amount that should prevent any sign of deficiency in at least 50% of people RDI recommended dietary intake o is the amount that should prevent any sign of deficiency in 97% of people o therefore rather higher than most individuals would ever need o it is wrong to diagnose a person as being deficient simply because their intake on a given day is a little below the RDI AI adequate intake o is an amount thats probably enough to avoid deficiency for most people o used instead of EAR and RDI where the available data for some nutrients were considered inadequate for estimating those nutrient reference values The NRVs are based on estimates of the amounts needed to avoid deficiency of a specific nutrient. Calculation of NRVs is based (where possible) on intervention studies, where volunteers are kept on a controlled diet known to be adequate for all nutrients bot one levels of that one nutrient are manipulated, and the volunteers are monitored of deficiency. UI upper level of intake This value indicates the quantity that may lead to toxic side-effects. This is the amount above which there is a significant risk of adverse effects from the nutrient.
2.
eat plenty of vegetables (including legumes), and fruits eat plenty of cereals (including breads, rice, pasta and noodles), preferably wholegrain include lean meat, fish, poultry and/or alternatives such as legumes and nuts include milk, yoghurt, cheeses and/or alternatives drink plenty of water Take care to limit saturated fat, and moderate total fat intake choose foods low in salt if you choose to drink, limit alcohol intake consume only moderate amounts of sugars, and foods containing added sugars
3. Prevent weight gain by being physically active and eating according to your needs 4. Care for your food and keep it safe to eat 5. Encourage and support breastfeeding
Low fluid intake may cause cognitive impairment, constipation, kidney stones, possible urinary tract infections While water is the preferred drink, the report also recognises milk and fruit juice as beneficial, having both water and important nutrients Tea is a useful source of antioxidants Because of their diuretic effect, excessive intake of alcohol, coffee and energy drinks (e.g. caffeine) can be dehydrating
Take care to limit saturated fats, and limit/moderate total fat intake This reflects concerns about o obesity (a reduction in total fat intake can help an individual lose weight) o coronary heart disease (recommended reductions in intake of saturated and trans fatty acids, a moderate increase of 6 polyunsaturated fatty acids, and a doubling of 3 polyunsaturated fatty acids Take care to choose foods low in salt The last decade has produce an international consensus that a modest sodium reduction for people with normal and raised blood pressure has a large enough effect on blood pressure to justify a guideline advocating restraint for the entire population. The emphasis is on foods low in salt; salt added in cooking and at the table is only a small proportion of total sodium intake If you choose to drink, take care to limit your alcohol intake Men 2 standard drinks per day Women 1 standard drink per day
Post-prandial state
Post-prandial state (meaning after a meal) is also known as the absorptive state. It takes place during roughly the first 4-6 hours after a meal. 1. Recent feeding high plasma levels of glucose, amino acids and triglycerides o these are derived from digestion and subsequent processing of dietary proteins, carbohydrates and fats 2. High plasma glucose levels stimulate insulin release and suppress glucagon release o therefore high insulin, low glucagon in plasma 3. Insulin promotes fuel storage
Page 70
o promotes uptake of glucose from plasma into adipose and muscle cells o stimulates the synthesis of glycogen stores (liver, muscle) and triglyceride stores (adipocytes) o stimulates protein synthesis in cells 4. Most cells are using glucose from plasma as a major fuel at this stage
4. Most tissues (except for the brain and RBCs) are using fatty acids and/or ketone bodies as their main fuel. glucose supplies are reserved for glucose-dependent cells in prolonged starvation, the brain starts to use ketone bodies as a fuel
ATP
Adenine is a nitrogenous base It is used in ATP, and in the related substances ADP and AMP These are all technically adenine molecule (mononucleotides), but they differ in the nature of their phosphate component.
ATP (adenosine triphosphate) adenine+ribose+phosphate+phosphate+phosphate ADP (adenosine diphosphate) adenine+ribose+phosphate+phosphate AMP (adenosine monophosphate) adenine+ribose+phosphate ATP acts as a direct energy source for reactions in a cell; if a cells supply of ATP is sharply reduced, it dies. An adequate supply of ATP is crucial for cell functioning, and cell survival When a cell splits stored ATP into ADP (or in some situations, AMP) then this provides energy for the synthesis of important molecules (including proteins, adipose triglycerides, glycogen, DNA) and for processes that require energy (e.g. pumping molecules across cell membranes against concentration gradients). A cell that cannot do such things rapidly, dies. Each cell must make its own ATP via the catabolism of fuels. Dietary ATP/ADP/AMP is completely digested in the gut ATP/ADP/AMP cannot leave cells So, administering them orally or by injections is completely useless Each cell has to make its own Cells engage in catabolic process, metabolising fuels to ensure that they have enough ATP Catabolism yields energy That energy is used to drive the following reaction:
Because each cell has a pretty constant amount of adenine, a rise in ATP levels means that ADP and AMP levels fall, and vice versa.
Page 73
Aerobic catabolism
Aerobic catabolism of all common fuels has three key stages.
Stage A: preliminary processing to create an intermediate of the TCA [Krebs] cycle different for various fuels
For some fuels, this stage occurs partly in the cytoplasm (cytosol); for others, it occurs in the mitochondria. a. obtain fuel molecule (from body stores or blood) b. convert it to an intermediate of the TCA cycle (that enter stage B) This stage includes oxidation steps that use oxidised coenzymes and yield reduced coenzymes (that enter stage C).
Acetyl-CoA Acetyl-CoA
Aminoacids
Alchol
Firs step is transamination to remove amino group (which end up in waste-product urea). The fate of the remaining part of the AA molecule varies between AA. Alcohol acetaldehyde acetyl-CoA
Acetyl-CoA
Page 75
Process 2: Plasma triglyceride (carried on the particles chylomicra or VLDL) releases its fatty acids. These enter the cell, and become FA-CoA. Process 3: Finally, 3 FA-CoA combine with one glycerol-3-P to form a triglyceride molecule The key enzyme is lipoprotein lipase o This enzyme (found on blood vessel walls near adipocytes) works on both chylomicra or VLDL, to carry out the reaction TG FA + glycerol ATP is needed for key steps o glucose glycerol-3-P (in glycolysis) o FA FA-CoA Insulin is crucial for key steps o Entry of glucose into adipose cell, and activation of lipoprotein lipase
Page 77
Like protein, which is a polymer of amino acids, DNA is a polymer of nucleotide subunits. A nucleotide consists of 3 distinct components: a phosphate group (1 to 3) a rubose sugar, and a base. DNA is a deoxyribose nucleic acid - each nucleotide consists of a phosphate, a deoxyribose and one of four bases.
About nucleotides: Nucleotides are linked to each other by a single phosphate group between deoxyriboses. This forms a linear, unbranched polymer. The nucleotides have a direction. Just like a protein has an NH2 and a COOH end, DNA has a 5' end and a 3' end. The new nucleotides are added on the the 3'-OH end during the synthesis of new DNA. They consist of a backbone (sugar-phosphate-sugar-phosphate - the orange part on the diagram above) with bases hanging off the backbone. There are four different bases: Adenine - TWO RINGS - PURINE Gunanine - TWO RINGS - PURINE Cytosine - ONE RING - PYRIMIDINE Thymine - ONE RING - PYRIMIDINE
Page 78
The convention is to simply write the order of bases (or nucleotides) in the 5' to 3' direction, as for protein amino acid sequence. E.g. 5' AGC TAC CTG AAA 3'.
Base pairing
Watson and Crick found that DNA strands H-bond together in pairs, so normally DNA from cells is double stranded. Its normal conformation is twisted into 2 helices - the 'double helix'. H-bond between strands is between purine and pyrimidine basis, and does not involve the ribose-P backbone. This is called base-pairing. Base-pairing combinations are restricted to just 2 different combinations: A always binds with T C always binds with G This sort of restriction exists because: The distance between the strands can only accommodate a purine:pyrimidine pair. The hydrogen bonds don't form between G and T, or A and C. The number of hydrogen bonds formed between G and C is 3 (remember because there are three letters between C and G!) and A and T is 2. So, DNA in one strand has the complementary sequence of the second strand.
E.g. AAA TTT CAG binds to the complimentary strand: TTT AAA GTC Note that to base pair, the 2 strands actually run in opposite directions. I.e.: 5' AAA TTT CAG 3' 3' TTT AAA GTC 5' But the convention is to write all sequences in 5' to 3' orientation, i.e. 5' CTG AAA TTT 3' is the second strand, called the reverse complement.
Page 79
DNA replication
All DNA in cells is double stranded, with the second strand the reverse complement of the first. The enzyme that makes the second strand is DNA polymerase. It synthesises new complementary strands, using each of the existing strands as templated. An incoming free nucleotide base-pairs opposite the existing base and is then added to the 3' end of the new DNA strand. An incorrectly base-paired nucleotide is released before it can be added to the 3' end of the new DNA strand. Both DNA strands are resynthesised before cell division, each new double-stranded DNA going to a daughter cell.
The DNA base sequence is the source of all amino acid sequences in polypeptides - the "Genetic Code"
We know that each protein has a specific, linear sequence of amino acids. DNA sequence of bases is also linear, and specific. In fact, the 2 sequences are co-linear - it is the sequence of bases in DNA that the cell "reads" or translates to specify the aminoacid sequence. The DNA sequence "codes" for the aminoacid sequence. Each aminoacid is represented by a specific 3-base sequence, called the codon. IMPORTANT THINGS TO REMEMBER ABOUT CODONS: The start codon: ATG. This is also methionine. This tells the cell where the coding sequence starts. The stop codons: TAG, TAA and TGA. This tells the cell where to end the polypeptide. (It is not translated into an amino acid). Remember redundancy. Many amino acids have more than one codon. The reason is that there are 64 possible codons (4x4x4), but only 20 amino acids. This means there is a redundancy in the code. The more commonly used amino acids have more than one codon.
Page 80
Open reading frame (ORF), also called the 'coding sequence', or CDS. This is the sequence that is translated into the amino acid sequence, it starts from ATG and ends at first 'in frame' stop codon. As the cell reads STRICTLY in codons, i.e., every 3 bases of sequence, the stop codon needs to be 'in frame' to be recognised, i.e., an exact multiple of 3 bases downstream from the start codon. E.g.: AAGGATGCAGACTAGATAGA is read as: A AGG ATG CAG ACT AGA TAG A, not A AGG ATG CAG AC TAG ATA GA.
Page 81
DNA polymerase has a number of requirements: 1. DNA is produced by copying a pre-existing strand 2. DNA polymerase cannot initiate a DNA strand - it requires a "primer" with a 3'-OH end. 3. DNA strand growth is in one direction only = 5' to 3'.
Page 82
The physical structure of DNA also provides a series of problems for replication, partly as a result of these 'rules' of replication: 3. Where to start? DNA synthesis begins at the replication fork, the site where the 2 DNA strands are separated. Eukaryotic DNA is very long, and therefore in humans, replication begins at multiple sites simultaneously (remember that it has to happen quickly). 4. DNA polymerase needs a 'primer' DNA strand with a free 2'-OH group to attach incoming nucleotides to. It cannot begin with a bare single stranded DNA alone. An enzyme called primase lays down a 'primer' strand for new dNTPs to be attached to by DNA pollymerase. This is made of RNA. 5. DNA polymerase can only synthesize in one direction (5' to 3'). Therefore, the two strands are made by slightly different mechanisms. For one strand, the leading strand, this occurs easily, while the other strand runs in the opposite direction, i.e. 3' to 5', the lagging strand and therfore has to be made in small sections. This is much slower, hence its name.
Page 83
The two strands are pulled apart, an RNA primer is laid down and DNA polymerase adds dNTPs onto the end of the primer for about 1000 bases. These are known as Okazaki fragments. A new RNA primer is then laid down closer to the replication fork as the DNA continues to open up, and a new Okazaki fragment is synthesized up to the previous fragment. The RNA primer is removed ad the 2 Okazaki fragments are joined or ligated together by an enzyme
Page 84
called DNA ligase. The lagging strand synthesis is thus discontinuous, while the other, 'leading' strand is continuous.
potentially less damaging since loss of some cells can be tolerated, unless the mutation establishes the neoplastic phenotype, which can lead to cancer.
DNA proof-reading
The chemistry of the DNA nucleotides can potentially interfere. A number of the bases can exist in alternate 'tautomeric' forms. There are isomers, a C=O bond becoming a C-OH, in cytosine for example. The majority of the time the bases exist in a single form, but rarely, about 1 in every 10,000 to 100,000 cytosine bases will be in alternate form and can switch transiently. This sort of base will hydrogen bond with adenine, not guanine, and potentially introduce a mutation into the daughter strand. If left in, a further round of replication will result in introduction of a T->C mutation. This is just a single example of mis-incorporation. This sort of mistake is avoided by the 'proof-reading' ability of DNA polymerases carried out as the DNA is being synthesized. The incorrect dNTP is incorporated onto the 3' end of the DNA strand. If base-pairing is disrupted, it doesn't proceed with synthesis, but removes the previous base with a 3'5' exonuclease activity. With correct base-pairing established, synthesis continues.
Page 86
RNA, or more specifically messenger RNA, is therefore an intermediate which links the DNA and protein codes. RNA is structurally similar to DNA except that: it contains ribose instead of deoxyribose it contains uracil instead of thyamine it is single-stranded Why do we need an intermediate (or messenger) to convert the DNA code to protein? Several key reasons: 1. Proteins are constantly being degraded and replaced, at different rates depending on which protein it is. 2. Not all proteins are expressed in a given cell, i.e. cells express different sets of proteins (e.g. heart muscle cell contractile proteins versus RBC hemoglobin), even though all cells contain all the genes. Some selectivity is required. 3. Different proteins are expressed in different amounts, so proteins levels have to be selectively altered. This can be done most easily by regulating the amount of RNA expressed. Consequently, DNA is constantly being transcribed, and translated into protein. So these processes don't simply happen when the cell first develops, and then stops.
Transcription
Transcription is the first step in converting the DNA code to protein, and involves the formation of an mRNA copy of the DNA. mRNA is synthesised by RNA polymerase. The mRNA is complimentary to the antisense, or non-coding DNA strand (by convention drawn as the bottom strand) and is therefore identical to the sense strand. The DNA is pulled apart by RNA polymerase, and travels along the DNA using the antisense DNA strand as a template for the RNA. RNA polymerase:
Page 87
Most of our DNA does not contain genes (or protein coding regions) so the RNA polymerase must be able to work out which bits need to be transcribed, i.e., it needs to know where to start and stop transcription. The DNA contains 'signal' sequences indicating where the polymerase should start or stop. The start signal is called the promotor - TATAAA (aka TATA box) The stop signal is called the terminator - AAUAAA on the RNA, AATAAA on the DNA. Without these sequences, transcription of a strand of mRNA cannot occur and therefore a protein cannot be produced. The promotor or TATA box is recognised by a protein called TATA binding protein. It binds to the promoter, recruits other factors including the RNA polymerase, so that transcription can occur.
The rate of transcription of genes (or gene expression) is controlled by a large group of proteins called transcription factors:
Page 88
increase or decrease the rate of transcription ("activation"/"repression"). Different transcription factors effect different genes, e.g., GATA is a transcription factor that alters expression of alpha-globin and beta-globin found in hemoglobin, but not contractile proteins, such as actin & myosin. Their expression may be cell-type specific, e.g., the transcription factor MyoD is expressed only in muscle cells. There are hundreds known Make up ~1% of the human genome
Transcription factors bind to specific DNA sequences These regulatory elements (sequences) are often referred to as 'enhancer elements' because they enhance the rate of transcription. They occur most frequently upstream, close to the TATA box, but can occur distantly, up to 50,000bp upstream or downstream from the coding sequence. Individual DNA regulatory elements are usually <20bp long.
Translation
Translation is the second step in converting the DNA code to protein, and involves the formation of an amino acid sequence from the mRNA. Translation requires three components: 3. mRNA - acts as the template for protein synthesis (generated during transcription) 4. transfer RNA (tRNA) - acts as an adaptor between the mRNA and the amino acid 5. ribosomes - the 'protein-making machines' tRNA:
A specialised RNA molecule. One specific amino acid is covalently bound to the 3' end. Folded into a 'clover leaf' shape exposing a 3-base "loop" (the anticodon loop) that base-pairs with the complementary base sequence in mRNA. The 'adaptor' molecule base-pairs with the mRNA, thus placing a specific aminoacid in position for addition to the peptide chain (protein) being synthesised on the ribosome. There are a variety of different tRNAs, each with a different aminoacid to one end, and a specific 3-base anticodon loop. Each 3 bases in the mRNA can therefore be translated into an aminoacid.
Page 89
Ribosomes
These are large, multiprotein particles. They bring together the mRNA, C-terminal end of peptide, and the tRNA molecules. They catalyse the addition of aminoacids from base-paired tRNA to C-terminal end of peptide chain. They move along mRNA 5' to 3'. Proteins are synthesised on ribosomes where the RNA sequence is 'read' or translated into protein sequence.
Page 90
The entire mRNA molecule does not encode for the aminoacid sequence, so there must be a signal for where protein translation should start and stop. Start codon ATG = Methionine. Translation starts at the first ATG in the sequence. This is recognised by a tRNA which is linked to the Met aminoacid. Each subsequent group of 3 bases is read by a tRNA and an aminoacid is added to the polypeptide chain. Contrast this to the promotor in transcription. Stop codon There are 3 stop codons (TGA, TAA, TAG). Translation stops at the first 'in-frame' (i.e. proper, in-line group of 3) stop codon. This is not recognised by a tRNA but by a release factor which releases the peptide chain from the ribosome.
Page 91
Page 92
General Pathology
Cellular responses to stress and noxious stimuli
The normal cell is confined to a fairly narrow range of function and structure, set by a number of factors, including: its genetic programs of metabolism, differentiation and specialisation constraints of neighboring cells the availability of metabolic substrates. Stimuli may provoke the cell to change its responses, but still maintain a relatively normal level of homeostasis. More severe physiologic stresses, however, and some pathologic stimuli, may bring about a number of physiologic and morphologic cellular adaptations, which entail now but altered steady states. These states preserve the viability of the cell and modulate its function as it responds to such stimuli. Hyperplasia is one adaptive response; it entails an increase in the number of cells. Contrastingly, hypertrophy represents an increase in the size of individual cells. Atrophy is the opposite, it is an adaptive response in which there is a decrease in the size and function of cells. The following table outlines some cellular adaptations to injury and some causes. Cellular responses to injury
Nature and severity of injurious stimulus Altered physiological stimuli: Increased demand, increased trophic stimulation (growth factors, hormones) Decreased nutrients, decreased stimulation Chronic irritation Reduced oxygen supply; chemical injury; microbial infection: Acute and self-limited Progressive and sever (including DNA damage) Mild chronic injury Metabolic alterations, genetic or acquired Prolonged life spa with cumulative sublethal injury Cellular response Cellular adaptations: Hyperplasia, hypertrophy Atrophy Metaplasia Cell injury: Acute reversible injury Irreversible injury cell death o Necrosis o Apoptosis Subcellular alterations in various organelles Intracellular accumulations; calcifications Cellular ageing
As detailed in the above table, some changes are more permanent than others. Cells have limits. If the limits of an adaptive response to a stimulus are exceeded, or if the cell is exposed to an injurious agent or stress, a sequence of events takes place that is loosely termed cell injury. Cell injury is reversible up to a certain point, but if the injurious stimulus is persistent, or is severe enough from the beginning, the cell reaches a point of no return and ultimately this ends in the death of the cell. Cells that are exposed to sublethal or chronic stimuli may not be damaged but may show a variety of subcellular alterations. Metabolic derangements in cells may be associated with intracellular accumulations of a number of substances, including proteins, lipids and carbohydrates. Calcium is often deposited at the site of cell death, resulting in pathologic calcification. Also, cell aging is also accompanied by characteristic morphologic and functional changes. The cellular response to an injury will always depend on the type, severity and duration of the injury, in addition to the type of cell (for example, neurons have different metabolic requirements than muscle cells). Some causative agents include: trauma thermal injury
Page 93
genetic abnormalities immunologic reactions poisons drugs infections organisms ionising radiation oxygen deprivation
There are a range of causative agents, but really only four actual cellular targets of injury: 1. External and internal cellular membranes 2. Aerobic respiration 3. Protein synthesis 4. Genetic apparatus
2. superoxide dismutase 3. glutathionine peroxidase Again, there are cells that vary in their ability to protect themselves from the effects of free radicals.
Mitochondrial damage
Mitochondria are typically a common direct or indirect target of cellular injury Damage of mitochondria leads to the formation of an abnormal channel a Mitochondrial Permeability Transition Pore (MPTP). Damage of mitochondria can also lead to the release of cytochrome C, a major initiator of the apoptotic pathways.
Lysosomes
Primary lysosomes in normal digestion fuse with vesicles containing material for digestion, and become secondary lysosomes, or phagoysosomes. Exposure to harmful stimulus could lead to repeated lysosomal fusing and digestion and swelling of the cell. Heterophagy is when material is taken up from the external environment. Autophagy is where cellular elements are bound up in an autophagic vacuole which fused with a primary lysosome and are digested. Lysosomes may contain indigestible material (such as lipofuscin pigment granules).
Page 95
Mitochondrial alterations
Mitochondria, in response a stress or injurious stimulus, may: Swell Increase in number (this makes sense because a cell under stress requires more energy) (associated with cell swelling) Reduce in number (associated with cell shrinkage) Become abnormal (e.g. megamitochondria in hepatocytes)
Cytoskeleton
The proteasome and heat schock proteins have a role in binding to and degrading proteins. Heat shock proteins are chaperone proteins and have a normal role in protein folding. The ubiquitin-proteasome system is involved in degrading proteins.
Tissue changes
Physiological adaptation is a process involving normal signalling mechanisms. Pathological adaptation, however, is a response to various forms of injury. ATROPHY = decrease in cell size HYPERTROPHY = increase in cell size HYPERPLASIA = increase in cell number METAPLASIA = change of cell type (e.g. from a squamous epithelial cell to a cuboidal epithelial cell)
Atrophy
This involves the loss of cell substance leading to cell shrinkage. A cell that has undergone atrophy may have decreased function, but it is not dead.
Page 96
The causes of atrophy are: 1. decreased workload 2. loss of innervation 3. loss of endocrine situation 4. ageing Atrophy is a cell survival strategy as a response to diminished use, supply or signalling. It is a reduction in structural components of the cell, achieved through decreased synthesis and increased degradation.
Hypertrophy
Hypertrophy is the increase of the size of cells, and results in the increase in the size of an organ. Structurally, it is the opposite of atrophy. Hypertrophy can be physiological (for example, the cells of the uterus during pregnancy undergo hypertrophy), or it can be pathological (for example, the cells of the myocardium after hypertension). It results from an increased functional demand, or from extracellular signalling.
Hyperplasia
Hyperplasia is the increase in number of cells in a tissue or organ. Hyperplasia is often linked with hypertrophy. A hyperplastic response is usually controlled, but may be pre-cancerous.
Metaplasia
Metaplasia is the process whereby an adult cell type is replaced by another adult cell type. The change of cell type is intrinsically designed to resist stress. A key example is the effect of smoking on ciliated columnar cells of the upper respiratory tract; they become stratified squamous epithelial cells and have decreased mucous secretion. There is the suspicion that metaplasia and neoplasia may be linked.
Page 97
The following table is an essential, basic summary of the key difference between the two processes.
Feature Cell size Nucleus Plasma membrane Cellular contents Adjacent inflammation Physiologic or pathologic role Features of Necrosis and Apoptosis Necrosis Enlarged (swelling) Pyknosis karyorrhexis karyolysis Disrupted Enzymatic digestion; may leak out of cell Frequent Always pathologic (culmination of irreversible cell injury) Apoptosis Reduced (shrinkage) Fragmentation into nucleosome size fragments Intact, but with altered structure (orientation of lipids) Intact; may be released in apoptotic bodies No Often physiologic (as a means of eliminating unwanted cells); may be pathologic after some forms of cell injury, particularly DNA damage
Apoptosis
Apoptosis is a pathway of cell death regulated by and induced by intracellular programming, in which, essentially, cells that intend to die activate enzymes that degrade the cells own DNA and the proteins inside its nucleus and cytoplasm. The cells own membrane remains intact, but changes in such a way that the apoptotic cell becomes a good target for the bodys phagocytes. The dead cell is rapidly cleared away before its contents leaks, so that the (cytokine-activated) inflammatory process does not begin.
a defence mechanism against viruses and tumours that serves to eliminate virus infected and neoplastic cells
Morphology of apoptosis
The following morphological features (seen mainly, or at least better, under an EM) characterise cells that are undergoing apoptosis. 1. Cell shrinkage cell is smaller in size cytoplasm is dense, organelles, although relatively normal, are more tightly packed 2. Chromatin condensation the most characteristic feature of apoptosis the chromatin aggregates peripherally, under the nuclear membrane, into dense masses of various shapes and sizes the nucleus itself may break up, producing two or more fragments 3. Formation of cytoplasmic blebs and apoptotic bodies the apoptotic cell first shows extensive surface blebbing, then undergoes fragmentation into membrane-bound apoptotic bodies composed of cytoplasm and tightly-packed organelles, with or without nuclear fragments 4. Phagocytosis of apoptotic cells or cell bodies, usually by macrophages the apoptotic bodies are rapidly degraded by lysosomes in the macrophages adjacent healthy cells migrate or proliferate to replace the space occupied by the now deleted apoptotic cell
Mechanism of apoptosis
Apoptosis as a mechanism can be divided into four linked steps.
Page 99
1. Induction/Signalling phase a. Intrinsic b. Extrinsic (both discussed shortly) 2. Effector phase a. Cell becomes committed to die b. Activation of cell executioner pathway c. Point of no return d. May be linked to mitochondrial permeability and release of factors 3. Degradation phase a. Main set of enzymes involved in apoptosis caspases b. Caspases are a family of aspartate-specific cysteinyl proteases c. Some caspases have initiator role (caspases 2, 8, 9 and 10) d. Other caspases have an effector or downstream role (casoases 3, 6 and 7) 4. Phagocytic phase a. Cell fragments produced by apoptosis are recognised by macrophages and other phagocytic cells b. Expression of specific signals on the membrane may facilitate phagocytic recognition Initiation of apoptosis occurs principally by signals from two distinct but converging pathways: the extrinsic (or receptor-initiated) pathway, and the intrinsic (or mitochondrial) pathway. Both pathways converge to activate caspases.
The Extrinsic (Death-Receptor Initiated) Pathway This pathway is initiated by the engagement of cell surface death receptors on a variety of cells. The reception of certain ligands activates an enzyme that triggers a cascade of caspase activation by cleaving and thereby activating other pro-caspases, and the active enzymes mediate the execution phase of apoptosis. The Intrinsic (Mitochondrial) Pathway This pathway is the result of increased mitochondrial permeability and release of pro-apoptotic molecules into the cytoplasm, without a role for death receptors. Key principle increased mitochondrial permeability release of pro-apoptotic molecules that are normally sequestered within the mitochondria. Mitochondrial changes are critical to apoptosis for both pathways. Changes in mitochondrial membrane permeability result in the formation of a Mitochondrial Permeability Transition Pore Complex (MPTPC), also known as a mitochondrial megachannel. This results in:
Page 100
releasing of cytochrome C and apoptosis initiating factor (AIF) formation of apoptosome and activation of caspases Causes of the specific mitochondrial permeability include free radical species, high intracellular calcium and the aforementioned extracellular death signals. Additionally, the lecture notes stipulate two additional pathways leading to apoptosis: 1. Cell membrane damage 2. Irreparable DNA damage DNA Damage Pathway Damage to DNA results in the mobilisation of cellular pathways leading to repair. But, if repair fails, there is an increase in pro-apoptotic factors and the cell kills itself.
Necrosis
Necrosis refers to a spectrum of morphologic changes that follow cell death in living tissue, largely resulting from the progressive degredative action of enzymes on the lethally injured cell. That is, necrosis is not actually the death of the cell, it is the degradation that follows it. Necrotic cells are unable to maintain membrane integrity and their contents often leak out, which may elicit inflammation in the surrounding tissue. The enzymes that denature the cell can be derived either from the lysosomes of the cell themselves, in which the process is called autolysis, or from the lysosomes of immigrant leukocytes, during inflammatory reactions. Because of this, these processes require hours to develop, and so there would be no detectable changes in cells if, for example, a myocardial infarct caused sudden death (we would have to look for other clues, like the occlusion of an artery). Usually, necrosis is detectable at its earliest at 4 to 12 hours after the necrotic activity.
Morphology of necrosis
General changes: Necrotic cells show increased eosinophilia, due in part to the loss of the dark-staining RNA in the cytoplasm, and due in part to the increased binding of eosin to the denatured proteins inside the cytoplasm Usually, the cells have a more glassy, homogenous appearance, mainly as a result of the loss of glycogen particles Calcification of the dead cells may occur Under EM, necrotic cells are characterised by overt discontinuities in plamsa an organelle membranes, marked dilation of mitochondria with the appearance of large amorphous densities, intracytoplasmic myelin figures, amorphous osmiophilic debris, and aggregates of fluffy material probably representing denatured protein Nuclear changes: These changes appear in the form of one of three patterns, all due to the non-specific (general) breakdown of DNA. The following may occur: Pyknosis nuclear shrinkage and increased basophilia, where the DNA apparently condenses into a solid, shrunken basophilic mass. Karyolysis the basophilia of chromatin may fade Karyorrhexis where the pyknotic or partially pyknotic nucleus undergoes fragmentation With the passage of time (a day or two), the nucleus in the necrotic cell totally disappears Tissue changes: Coagulative necrosis
Page 101
o This is characterised by when denaturation is the primary pattern o It implies preservation of the basic outline of the coagulated cell for a span of at least some days o Cellular detail and tissue architecture relatively preserved o Firm, pale, cooked appearance o Characteristic of hypoxic cells in all tissues except the brain Liquefactive necrosis o A characteristic of focal bacterial (or occasionally fungal) infection because microbes stimulate the accumulation of inflammatory cells o Hypoxic death of cells in the CNS result in liquefactive necrosis, for reasons too complicated to go into now o Whatever the pathogen, liquefaction completely digests the dead cells o The end result is transformation of the tissue into a liquid, viscous mass o If the process is initiated by acute inflammation, the material is frequently yellow and creamy because of the presence of white cells and is termed pus Gangrenous necrosis o Combination of the features of ischemic coagulative necrosis plus a liquefactive component o Usually applied to a limb that has lost its blood supply and has undergone coagulative necrosis, and a bacterial infection has been superimposed Caseous necrosis o A distinctive form of coagulative necrosis o The term caseous is derived from the cheesy, white gross appearance of the necrotic area o On microscopic examination, the necrotic focus appears as amorphous granular debris, seemingly composed of fragmented, coagulated cells and amorphous granular debris enclosed within a distinctive inflammatory border known as a granulomatous reaction o Unlike coagulative necrosis, the tissue architecture is completely obliterated Fatty necrosis o Does not denote a specific pattern of necrosis, but rather is a descriptive term describing areas of fat destruction, typically occurring as a result of the release of activated pancreatic lipases into the substance of the pancreas and the peritoneal cavity o Occurs during acute pancreatitis, where lipids from cells are broken down and combine with calcium to produce grossly visible chalky white areas, called fat saponification o Histologically, the necrosis takes the form of shadowy outlines of necrotic fat cells with basophilic calcium deposits, surrounded by an inflammatory reaction Haemorrhagic necrosis o Features dead tissue suffused with extravasated red cells o Common when cell death is due to blockage of venous drainage, resulting in a massive congestion of blood and poor perfusion
Left: Tuberculous lung featuring caseous necrosis; right: foci of fat necrosis with saponification in the mesentery
Page 103
Inflammation
Inflammation is a complex reaction to injurious agents such as microbes and damaged, usually necrotic, cells that consists of vascular responses, migration and activation of leukocytes, and system reactions. The reaction of blood vessels is a unique feature of inflammation that leads to the accumulation of fluid and leukocytes in extravascular tissue. The process of inflammation is closely intertwines with the process of tissue repair, and inflammation is fundamentally a protective response, consisting of four main components: 1. a vascular reaction (dilatation of blood vessels endothelial leakiness 2. movement of protein-rich exudate 3. recruitment of cells (e.g. leukocytes) 4. proliferative activity (tissue regeneration, granulation and healing) There are two types of inflammation: 1. Acute inflammation: the initial, transient response 2. Chronic inflammation: the subsequent, prolonged response Before describing in detail the processes of inflammation, we should make some definitions. EXUDATION = the escape of fluid, proteins and blood cells from the vascular system into the interstitial tissue or body cavities. EXUDATE = an inflammatory extravascular fluid that has a high protein concentration, cellular debris, and a specific gravity above 1.020. It may also contain: immunoglobulins (e.g. to target microorganisms for neutrophil phagocytosis) coagulation factors and precursor protein (fibrinogen leads to the formation of filamentous fibrin threads); helps immobilise microorganisms and assist the migration of neutrophils TRANSUDATE = a fluid with a low protein content (in contrast with an exudate). EDEMA = denotes an excess of fluid in the interstitial or serous cavities. The fluid can be exudate or transudate. PUS = a purulent exudate, is an inflammatory exudate rich in leukocytes (mostly neutrophils), the debris of dead cells and in many cases, microbes.
Acute inflammation
This section aims to equip the student with knowledge of: vascular and fluid changes in inflammation the mobilisation and role of leukocytes the forms of acute inflammation the beneficial and harmful consequences of inflammation the outcomes following acute inflammation
4. Increased transcytosis across the endothelial cytoplasm vascular endothelial growth factor (VEGF) appears to increase this 5. Leakage from new blood vessels when endothelial cells proliferate at the healing stages of inflammation, the vessels remain leaky this contributes to the oedema that is characteristic of the early phases of healing that follow inflammation
Page 106
Convert soluble fibrinogen into fibrin Fibrin is a significant component of exudate 2. Kinin system Structurally-related polypeptides Activation of the kinin system results in the release of the vasoactive bradykinin, which increases vascular permeability and causes contraction of smooth muscle, dilation of blood vessels, and pain when injected into the skin (effects similar to those of histamine) 3. Thrombolytic (fibrinolytic) system Generates plasmin to degrade fibrin 4. Complement system A large family of proteins that are synthesized in the liver, and circulate in the vascular system Dead cells, bacterial endotoxins, antigen-antibody complexes, products of the kinin and fibrinolytic pathways can all activate complement Example roles in inflammatory reaction a. C5a: chemotactant for neutrophils, increase vascular permeability, increase histamine release from mast cells b. C4b, 2a, 3b: opsonisation of bacteria (facilitates phagocytosis)
o Staging of cellular changes o Mediators of successful and unsuccessful healing Knowledge of the cellular features of healing by primary or secondary intention
Page 109
However, this process is not common. It is limited to certain cell types (lung, liver kidney, and not the heart and brain). It results in the restoration of normal tissue, and the removal of the harmful agent/microorganism. Vascular permeability returns to normal.
Healing of skin
Healing by primary or first intention This occurs in closely apposed surfaces with a narrow space, minimal dead tissue (for example, when a wounds edges are held together by sutures). Healing by second intention
Page 110
This occurs in the healing of open wounds; it takes longer, and results in a larger scar. It is aided by wound contraction by myofibroblasts.
Skin sutures and wound strength 1 week sutures removed 10% tensile strength of normal skin 1 month 50% strength 3 months 80% strength
Page 111
Summary diagram
Chronic inflammation
Chronic inflammation is difficult to define, but essentially it is inflammation of prolonged duration (weeks or months) in which: active inflammation, tissue destruction, and
Page 112
attempts at repair are all occurring simultaneously. Although it may follow acute inflammation, it frequently begins as an insidious (often) asymptomatic response. This type of chronic inflammation is the cause of tissue disease in some of the most common and disabling human diseases such as rheumatoid arthritis, atherosclerosis, tuberculosis, and chronic lung diseases.
1. Recruitment of monocytes from the circulation with the expression of chemotactic factors (like the attraction of neutrophils in acute inflammation) 2. Local proliferation of macrophages after their immigration from the bloodstream 3. Immobilisation of macrophages within the sit of inflammation. Certain cytokines and oxidised lipids can cause such immobilisation The products of activated macrophages serve to eliminate injurious agents such as microbes and to initiate the process of repair, and are responsible for much of the tissue injury in chronic inflammation. These products can: be toxic to microbes and host cells be toxic to extracellular matrix be chemotactic to other cell types cause fibroblast proliferation, collagen deposition and angiogenesis. Therefore, tissue destruction is one of the hallmarks of chronic inflammation. Other factors, in addition to the products of macrophages themselves, may contribute to tissue damage in chronic inflammation. Necrotic tissue can perpetuate the inflammatory cascade (through the activation of kinin, coagulation, complement and fibrinolytic systems) The release of mediators from leukocytes responding to the necrotic tissue Liberation of substances like uric acid from dying cells In cellular immune reactions, T lymphocytes may directly kill cells Thus, ongoing tissue destruction can activate the inflammatory cascade by diverse mechanisms, so that features of both acute and chronic inflammation may coexist in certain circumstances.
Lymphocytes
Lymphocytes are mobilised in both antibody-mediated and cell-mediated immune reactions and even in nonimmune inflammation. Lymphocytes and macrophages communicate bidirectionally. Macrophages present antigens to T cells and produce factors that activate them. T cells produce cytokines, and one of them is a major activator of macrophages. Plasma cells develop from activated B lymphocytes and produce antibodies directed against either the persistent antigen in the inflammatory site or against altered tissue components. This can look like secondary lymphoid tissue in severe chronic inflammation.
Eosinophils
These cells are particularly abundant in immune reactions against parasitic infections. Recruitment of eosinophils is similar to recruitment of neutrophils. They contain granules of major basic protein that is toxic to parasites but may also cause lysis of epithelial cells.
Page 114
Mast cells
Mast cells are widely distributed in connective tissue and participate in both acute and chronic inflammatory reactions. They usually secrete histamine when activated, which helps the bogy during anaphylactic reactions to foods, insect venom or drugs, but can backfire (with catastrophic results). When properly regulated, the response can be beneficial to the host. In chronic inflammatory reactions, they may produce cytokines that contribute to fibrosis.
Granulomatous inflammation
Granulomatous inflammation is a distinctive pattern of chronic inflammatory reaction characterised by focal accumulations of activated macrophages, which often develop an epithelioid appearance, also known as, epithelioid histiocytes. It is encountered in a limited number of immunologically mediated, infectious and some non-infectious conditions. Tuberculosis is the key demonstrative example of granulomatous diseases, but others include sarcoidosis, leprosy and syphilis. Histological recognition of the granulomatous pattern in a biopsy is essential because it significantly narrows the scope of the diagnosis.
Granuloma
GRANULOMA = a focus of chronic inflammation consisting of a microscopic aggregation of macrophages that are transformed into epithelium-like cells surrounded by a collar of mononuclear leukocytes, predominantly lymphocytes and occasionally plasma cells. In usual staining, the epithelioid histiocytes have a pale pink granular cytoplasm with indistinct cell boundaries, often appearing to blend or merge into one another. They can be distinguished from lymphocytes because their nuclei is less dense, is oval or elongate, and may show folding of the nuclear membrane. Older granulomas develop an enclosing rim of fibroblasts and connective tissue.
specific inflammatory or immune response. Epithelioid histiocytes and giant cells surround and encompass the foreign body Immune granulomas are caused by insoluble particles, typically microbes, that are capable of inducing a cell-mediated immune response. The prototype example is the bacillus of tuberculosis, which is classically categorised by the presence of central caseous necrosis (which is rare in other granulomatous diseases).
The picture above is a slide typical of tuberculosis. Note the area of central caseous necrosis, the giant cells (Langerhans type), the epithelioid histiocytes, and the many lymphocytes.
Page 116
Neoplasia
General facts about neoplasia
Neoplasia literally means new growth and is synonymous with the term tumour. Cancer is the common term for all malignant tumours. A neoplasm is an abnormal mass of tissue: 1. the growth of which exceeds normal tissue 2. that is uncoordinated compared with normal tissue 3. that persists after the cessation of the original stimulus. The persistence of tumourous growth after the cessation of stimulus is due to the hereditable genetic factors that are passed down to the affected cell progeny. These genetic changes allow excessive, unregulated growth/proliferation that becomes autonomous. (Although tumours generally remain reliant on the host for nutrition and blood supply. The entire population of a tumour arises from a single cell that has incurred genetic change; hence tumours are said to be clonal. All tumours, benign and malignant, have 1. Parenchyma (proliferative neoplastic cells), and 2. Stroma (connective tissue and blood vessels) We have recognised cross-talk between stromal and parenchymal cells which directly influences the growth and morphology of the tumour. Eg. stromal support scant? neoplasm is soft and fleshy parenchymal cells can stimulate the formation of abundant collagenous stroma (known as desmoplasia).
abnormally organised. Examples include, haemangioma, lymphangioma, rhabdomyoma of the heart, adenomas of the liver, pigmented naevi. HETEROTOPIA (also CHORISTOMA) = the presence of normal cells or tissues located in abnormal places. Examples include the residue of pancreatic tissue found in the wall of the stomach or small intestine, endometriosis.
Tumour history
The natural history of most tumours can be tracked under the following phases: 1. Malignant change in the target cell (transformation)
Page 119
2. Growth of the transformed cells 3. Local invasion 4. Distant metastasis We often separate benign and malignant neoplasms based on these phases, and usually, we can do so on the basis of morphology, with considerable confidence; some neoplasms, however categorisation.
3. MITOSES anaplastic tumours usually possess large amounts of mitotic processes however, the presence of mitoses do not necessarily indicate that a tumour is malignant or that a tissue is neoplastic, because many normal tissues exhibit high levels of mitotic activity (like bone marrow or tissues expressing non-neoplastic hyperplasia. so, the most important morphological feature of a malignant neoplasia is mitotic figures that are: atypical/bizarre in morphology tripolar or multipolar spindles 4. LOSS OF POLARITY the orientation of anaplastic cells usually indicates they have lost normal polarity or it has been markedly disturbed this can arise in sheets or large masses of tumour cells 5. OTHER CHANGES
Page 120
Tumour giant cells: often possessing a single huge polymorphic nucleus, others having many hyperchromatic nuclei. (Dont confuse these with inflammation-related macrophages whose nuclei will be small and round and appear normal) Sometimes blood supply is scant in tumours, and central areas may show signs of ischemic necrosis
There is a wide spectrum of levels of differentiation in tumours ranging from undifferentiated to fully differentiated, and the space between the two poles is termed moderately well-differentiated.
Dysplasia
Also important are a couple more terms in relation to tumour morphology. DYSPLASIA = a loss in the uniformity of the individual cells as well as a loss of their architectural orientation, with the following features: encountered principally in epithelium pleomorphism/polymorphism hyperchromatic, abnormally large nuclei normal, but increased mitotic activity (that may be in abnormal locations in epithelium) usually considered a preinvasive state Distinguishing dysplasia from anaplasia is through knowing that dysplastic tissues still somewhat resemble their mature tissue of origin. Think of the basal cell carcinoma, which is malignant but not anaplastic; it is dysplastic because the cells still resemble the basal cells of the stratum basale of the epidermis. Dysplasia displays the morphologic features of malignancy at a stage when invasion of surrounding tissue is not evident. When referring to epithelial tissue, it implies a reversible histologic deviation from normal, with deranged differentiation but controlled proliferation. A premalignant legion. CARCINOMA IN SITU = when dysplastic changed are marked and involve the entire thickness of the epithelium, but where the lesion remains confined to the normal tissue. The carcinoma-in-situ is considered a preinvasive neoplasm; when tumour cells move beyond the confines of the basement membrane, the tumour is said to be invasive. Dysplasia often predates the appearance of cancer. Clinically, benign neoplasms and well-differentiated carcinomas of endocrine glands frequently elaborate hormones of their origin, and can therefore be picked up in testing. If this occurs, we know the tumour is not anaplastic but more likely dysplastic.
Surface occurrence morphology: Sessile Papillary Polypoid Fungating Ulcerated Annular SCIRRHOUS = refers to hard tumours. MEDULLARY = refers to softer lesions.
Premalignant stages
Some tissues show dysplastic (abnormal tissue development) changes for a long period and then chance to carcinoma-in-situ, before becoming invasive cancers (e.g. uterine cervix carcinoma-in-situ). This stage is more easily recognised in epithelial tissues rather than non-epithelial tissues.
Neoplastic angiogenesis
Angiogenesis is the process in which tumours stimulate the growth of host blood vessels. Neoplastic angiogenesis is required for tumours beyond 1-2mm thickness in diameter, presumably because this is the maximum distance across which oxygen and nutrients can diffuse from blood vessels. Neovascularisation (new blood vessels) has a dual effect on the growth of the tumour: perfusion supplies nutrients and oxygen to the neoplastic cells new endothelial cells stimulate the growth of adjacent tumour cells by secreting polypeptide growth factors such as insulin-like growth factors and PDGF Tumour-associated angiogenic factors, produced by tumour cells (or may be derived from inflammatory cells that infiltrate tumours) promote vascular endothelial growth factor (VEGF) o induced by hypoxia, cytokines, GFs basic fibroblast growth factor (bFGF) o promote fibroblast migration and proliferation Evidence exists to suggest that early in the growth of a tumour, its cells do not express angiogenic factors but remain in-situ. When some cells within the tumour undergo a small tumour change to angiogenic phenotype, known as the angiogenic switch.
Page 122
Anti-angiogenesis factors (inhibitors) are also produced by tumour cells, and therefore the production of new tumour blood vessels rests on the balance between angiogenic factors and anti-angiogenic factors. Antiangiogenic factors include: thrombospondin-1 plaminogen angiostatin collagens endostatin, tumstatin (used experimentally to stop tumour angiogenesis in mice) A structural comparison between normal blood vessel networks and tumour blood vessel networks: Normal: Stable Structure and function of wall and network appropriate to location Clear distinction between arterioles, capillaries and venules Tumour: Unstable, evolving network Abnormal structure Abnormal function Inappropriate to location Arterioles, capillaries and venules not apparent
Local Invasion
1. Invasion of extracellular matrix a. detachment of tumour cells from each other (loss of cadherins) b. attachment to components of the extracellular matrix c. degradation of the extracellular matrix d. migration of tumour cells (now it becomes metastasis) e.
Metastasis
Metastasis continues the process of invasion, at step two: 2. Vascular dissemination and homing of malignant neoplastic cells a. platelet-tumour aggregates b. adhesion to endothelium c. crossing through basement membrane and extravasation d. metastatic deposit, angiogenesis, and growth
Metastasis unequivocally marks a tumour as malignant because benign neoplasms do not metastasise. With few exceptions, all cancers can spread. The notable exceptions are the gliomas (in the CNS) and the squamous cell carcinomas of the skin. Both these cancers are highly locally invasive, but rarely metastasise. In general, the more aggressive, rapidly growing, and larger the primary neoplasm, the more likely it is to metastasise. But, there are plenty of exceptions. This is a general principle. The following diagrams represent the process of invasion, left, and metastasis via the hematogenic pathway (discussed later), right.
Page 124
Possible methods of metastasis transport include: lymphatics spread hematogenous spread seeding of body cavities These mechanisms provide pathways to other tissues. Seeding of body cavities and surfaces can occur anywhere there exists a natural open field and the cancer has invaded in a way that exposes itself to the field most often involved the peritoneal cavity, but many others also
Page 125
Lymphatic spread most common pathway for the initial dissemination of carcinomas sarcomas may also use this route, but it is less common important: the pattern of lymph node involvement follows the natural route of lymphatic drainage sometimes performing a full lymph node dissection close to the presence of a tumour can be beneficial to prevent its spread, but this surgery can present significant morbidity, so more commonly, the sentinel nodes will be biopsied. A sentinel node is the first node in a regional lymphatic basin that receives lymph flow from the primary tumour Englargement of lymph nodes under the system presence of cancer can be due to one of the following: the spread of, and growth of, cancer cells, or hyperplasia of the immune tissue, reactive to the cancer. Hematogenous spread the most common pathway for the dissemination of sarcomas veins are more often penetrated than arteries (because they generally have thinner walls) with venous invasion, the blood-borne cancer cells follow the path of venous flow hence, the liver and lungs are the most commonly involved organs in secondary dissemination, because all portal area draining flows to the liver, and all caval blood flows to the lungs
Aetiology
Environmental carcinogenic/tumourgenic factors: chemical agents radiation viruses bacteria fungi parasites acquired pre-neoplastic disorders: cirrhosis pernicious anaemia (associated with vitamin B12 deficiency) ulcerative colitis (ulceration of the colon and rectum, cause unknown) leukoplakia (white patch of oral mucous membrane associated with pipe smoking) altered immune states Hereditary neoplastic syndromes: familial adenomatous polyposis (polyposis of the colon that usually begins in childhood, and increases with age) familial retinoblastoma cancers without recognisable genes or transmission pattern autosomal recessive syndromes increased susceptibility to environmental carcinogens
Epidemiology of neoplasms
More common in adults: colorectal carcinoma bronchial carcinoma
Page 126
mammary carcinoma prostatic carcinoma More common in children: leukaemia/lymphoma brain tumours neuroblastoma nephroblastoma
4. These genes affect cell proliferation or survival indirectly 5. Carcinogenesis is a multistep process at both the phenotypic and the genetic level 1. Nonlethal genetic damage lies at the heart of carcinogenesis such genetic damage may be acquired by the action of environmental agents such as chemicals some may be inherited by the germ line not all damage has exogenous causes, some causes are spontaneous and stochastic 2. Clonal expansion monoclonal cancers certain molecular markers exist that indicate that cancers have such clonality 3. Four classes of regulatory genes are the principle targets of genetic damage 1. the growth-promoting oncogenes 2. the growth-suppressing tumour-suppressor genes 3. genes that regulate apoptosis 4. genes involved in DNA repair 4. DNA repair genes affect cell proliferation or survival indirectly they do so indirectly by influencing the ability of the organism to repair nonlethal damage in other genes, including protooncogenes, tumour suppressor genes, and genes that regulate apoptosis 5. Carcinogenesis is a multistep process at both the phenotypic and geneotypic levels a malignant neoplasm has several phenotypic attributes discussed earlier, like excessive growth, local invasiveness and the ability to form distant metastases these characteristics are stepwise and are called, together, tumour progression at the molecular level, progression results from the accumulation of genetic lesions that in some instances are favoured by defects in DNA repair
Page 128
It is widely believed that the occurrence of mutations in cancer-causing genes is conditioned by the robustness of the DNA repair machinery of the cell. When genes that normally sense and repair genetic damage are impaired or lost, the resultant genomic instability favours mutations in genes that regulate the other acquired capabilities of cancer cells.
Skin tumours
Objectives for this section: 1. understand the cellular changes that characterise benign melanocytic neoplasms (naevi) 2. understand the cellular features of a malignant melanoma and know how these are used diagnostically 3. know the cellular changes underlying common non-melanoma malignant skin tumours (squamous and basal cell carcinomas) There are three major malignant skin tumours: 1. Squamous cell carcinoma 2. Basal cell carcinoma 3. Melanoma
Naevi
NAEVI = congenital lesion of the skin A naevi is a congenital or acquired neoplasm of melanocytes, with the following characteristics: uniform pigmentation light to dark brown in colour features elevation on skin (papules) has well defined borders is derived from melanocytes in the basal layer is made up of oval cells that grow in aggregates (nests) Junctional naevi early form of the melanocytic naevi grows along dermal-epidermal junction, giving pigmentation to the skin flat, uniformly pigmented usually develop in childhood/early adolescence features rounded nests of melanocytes shown below
symmetrical and uniformly pigmented histologically, features nests and cords of melanocytes extending into the dermis shown below
Intradermal naevi raised and usually smoothly domed typically has a uniform flesh colouration rarely occurs in children and adolescents confined entirely to the dermis may decrease in size with further age shown below
The vast majority of naevi are benign, and have well-differentiated individual cells. The melanocytes are organised in nests or in a linear (lentiginous) patters. But a junctional or compound naevus is at risk of developing into a dysplastic naevus.
Dysplastic naevus
Dysplastic naevus are characterised by the following features: relatively large in shape irregular edge, irregular surface, and irregular pigmentation often looks similar to a compound naevus, but the distinction is that it often has an asymmetric shoulder melanocytes show cellular atypia and increased mitoses the dermis shows linear or lamellar fibrosis there exists the possibility of an early malignant change these lesions should be excised
Page 130
In the right picure, you can see the presence of cytologic atypia (the irregularly shaped, dark-staining nuclei hyperchromatism). You can also see linear or lamellar fibroses in the dermis underneath the epidermis. Evidence exists to suggest that dysplastic naevi are the precursors of malignant melanomas.
Lentigo maligna
These lesions are common on the face of the elderly. They feature flat shape, with a variegated, irregular border. They have a brown or black colouration. Histologically, basal cells are replaced by a continuous line of atypical melanocytes.
Malignant melanoma
This is the most dangerous malignant skin cancer. It is a malignant melanocytic neoplasm that is more common in adults than in children. It may develop from previous lesions (from the dysplastic naevi or the lentigo maligna) or it may develop spontaneously They are more common in fair-skinned individuals UV exposure is the most significant predisposing factor
Morphological and histological features: Relatively large in size, and usually is presented accompanied by a history of a recent increase in size Irregular border and striking variations in colour (variable pigmentation) Some appear flat, some appear nodular Has the potential for ulceration of the lesion Very important concepts to remember about melanomas: 1. This is the skin cancer most likely to spread to other organs by metastasis
Page 131
2. Vertical and radial pattern of growth is vitally important There are three main subtypes of malignant melanomas.
Page 132
SCC in-situ
This is also known as Bowens disease. These lesions: feature red, sharply defined, scaling plaques do not penetrate epidermal-dermal junction
Invasive SCC
This tumour features:
Page 133
highly atypical cells in all layers of the dermis neoplastic cells penetrated through the basement membrane into the dermis cells which demonstrate variable levels of anaplasia and variable morphology, including: o polygonal squamous cells organised in lobules with keratinisation o rounded, highly anaplastic cells with limited keratin formation
Approximately 5% of these tumours metastasise to regional lymph nodes. Strong link to UV damage to DNA and/or suppression of repair mechanisms. Involves impairment of local immune cells, causing reduced antigen presentation and decreased immunosurveillance.
Histologically: The neoplastic cells resemble basal cells Mostly nodular lesions (some also cystic) o grows deeply into dermis o features multiple islands of basaloid cells o palisaded cells at periphery of islands o dark-stained nuclei, scant cytoplasm Scant ulcers are o unusually aggressive o may invade sinuses or bone
Page 134
Superficial BCC
A less common variation of the BCC Affects elderly, predom trunk Flat in structure Red, scaly, patchy appearance may have raised pearly papules, resembling nodular form
Seborrheic keratoses
These are common in middle to older aged people. They are typically localised to the trunk, but also can occur on limbs, head and neck. It is common to find inflammation associated with a seborrheic keratoses.
Page 135
They appear as round, flat, coinlike, wazy plaques that vary in diameter from millimetres to several centimetres. They can have a melanoma-like appearance, but the thing that distinguishes them from melanomas is the presence of prominent keratin-filled horns.
Keratoacanthoma
Acanthosis refers to the thickening of the stratum spinosum. These are rapidly growing neoplasms that may mimic well-differentiated squamous cell carcinomas both histologically and clinically. They often heal spontaneously, without treatment. They usually appear on areas exposed to the sun, and can grow to 1cm in diameter or more. They have a central, keratin-filled crater surrounded by proliferating epithelial cells that extend upwards in a liplike fashion over the sides of the crater and downward into the dermis as irregular tongues.
Page 136
The stratum corneum in an actinic keratosis is thickened, and features nuclei cells, unlike normal skin. This is a pattern termed parakeratosis. Some of these lesions produce so much keratin that a cutaneous horn develops, as seen in the picture.
Page 137
Homeostasis
Body fluid compartments
Learning outcomes: Describe the major fluid compartments in the body Explain how water moves between fluid compartments and how water may enter and leave the body Discuss the pressures involved in the movement of fluid between capillaries and interstitial spaces. State the roles of the major solutes in each fluid compartment Link the above to fluid shifts that occur after burns Fluid compartments are separated by selectively permeable membranes and comprise of: Total body water volume - 40 litres - 60% body weight, comprised of Intracellular fluid volume - 25 litres - 40% body weight Extrecellular fluid volume - 15 litres - 20% body weight, which is comprised of Plasma volume - 3 litres - 20% of extracellular fluid volume Interstitial fluid volume - 12 litres - 80% of extracellular fluid volume Clinically, plasma is the first access to body fluid and has significant clinical application (IV access, fluid replacement, etc.)
Page 138
Page 139
Fluid input comprises: 7. metabolic water 8. ingested foods and ingested liquids Fluid loss comprises: losses from the gastrointestinal tract lungs skin (sweating etc.) kidneys (excretion) Water is in a state of constant flux between fluid compartments
Water balance
Water balance is maintained by: 5. Regulating water input (the thirst mechanism) 6. Regulating water output (the renal system, antidiuretic hormone)
Thirst mechanism
Page 140
Capillary hydrostatic pressure filtration (24 litres per day) and osmotic pressure reabsoroption (20 litres per day) are in near equilibrium. The near equilibrium between filtration from capillaries to the interstitial space and reabsorption from the interstitial space into the capillaries is referred to as Starling's Law of the Capillaries. The net outward force results in a flow of fluid that contributes to a moist interstitial space, skin turgor and a positive interstitial fluid pressure. This net outflow of fluid (3-4 litres per day) is collected by lymphatic capillaries and returned to the cardiovascular system.
Page 141
Plasma to interstitial (some causes and outcomes): Oedema Filtration from capillaries favoured or reabsorption impaired Inflammation (increases permeability) altered filtration coefficient Increased blood volume (renal failure, fluid overload and congestive heart failure) increased capillary hydrostatic pressure Decreased serum albumin (malnutrition, burns and kidney disease) decreased colloid osmotic pressure Pulmonary oedema (congestive heart failure, inflammation) Pitting oedema of lower leg
Page 142
Weeping oedema Interstitial to plasma: Short term adaptive response to a sudden decrease in plasma volume (PV) or high interstitial fluid volume (IFV) Haemorrhage Later stages of burns Stabilisation of hemodynamic variables in the case of hypovolemia Burns (hypervolemia) Review of key points so far 6. Capillary network supplies almost all tissues in body with substrate necessary for homeostasis 7. The balance of Starling Forces determines net fluid movement across capillary endothelium 8. The process of diffusion is most important for solute exchange 9. Burns lead to an increase in capillary permeability, loss of plasma proteins and an imbalance in Staling Forcess that promotes the formation of oedema and a loss of plasma volume
Burns
Due to thermal or chemical injury to the skin Rule of nines Categorised according to depth and extent First, second and third degree burns vs partial and full thickness burns More than 20% third degree burns = significant risk of death
First degree: only epidermis involved painful and moist (think why) heals without scarring Second degree: total epidermis, some dermis generally painful and moist, often blisters Third degree complete epidermis and dermis painless, varied appearance problems - shock, electrolyte, imbalance, infection
Page 143
Be aware that intravascular fluid (aka plasma) and interstitial fluid is collectively termed extracellular fluid.
Chloride
Major extracellular anion Balances osmotic pressure Combines with H+ to form HCl in gastric acid
Calcium
Most abundant ion Important in bone growth and metabolism Participates in blood coagulation Essential for muscle tone
Page 144
Metabolic process produce heat as a by product. The efficiency of most human metabolic reactions is about 50%. Mammals and birds are able to store a portion of this heat in their body and so maintain their body temperature at a level above that of the surrounding environment. This classifies them as endotherms (produced its own heat) . Mammals (humans included) and birds are also able to maintain their body temperature within a fairly narrow range. This classifies them as homoiotherms. The tissues of the body producing the majority of the body heat make up the body core. The layer of tissues outside of the core, forming a 'buffer zone' between the core and the environment, is termed the body shell. The skin forms the outermost layer of the body shell.
This table shows the skin temperatures of an adult male resting in a thermoneutral environment (~29C). (A thermoneutral environment is one where the termperature is such that we do not have to create or lose heat, i.e., we don't require cooling or thermogenesis). Region Head (highest) Trunk (highest) Upper arms Forearms Hands (lowest) Thighs Calves Feet (lowest) Area (m2) 0.20 0.70 0.10 0.08 0.07 0.33 0.20 0.12 Total = 1.80 m2 Percent of total body surface area 6% 36% 8% 6% 5% 19% 13% 7% Skin temperature (degrees C) 34.6 C 34.6 C 33.0 C 30.8 C 28.6 C 33.0 C 30.8 C 28.6 C Mean = 33.0 C
Vertical: temperature of various body parts Horizontal: ambient temperature As seen on the graph, temperature does not vary linearly in various body parts with ambient temperature. With a rise in ambient temperature, the temperature of different body parts will change differently to others. For example, feet will jump quite a lot in temperature, while rectal temperature stays fairly constant.
Page 145
We can see from the above diagram that skin plays the role of both sensor and effector. A sensor role is provided by the presence of thermoreceptors in the skin that respond to local changes in temperature. An effector role is provided by blood vessels supplying the skin and by sweat glands located within the skin.
Skin thermoreceptors
We now know that all temperature sensors in the skin are in the form of free nerve endings without any specialised structure whatsoever. Cold sensors increase their firing rate as skin temperature falls, whereas warm sensors increase their firing rate as skin temperature rises. Over most of the skin surface, cold sensors considerably outnumber warm sensors. In a few areas, however (e.g. the scrotum) the situation is reversed and warm sensors predominate. There is quite a lot of overlap in the temperatures at which cold and warm sensors are active. Both are generally active around a mean skin temperature of ~33 C. This means that cold and warm receptors are active together a lot of the time.
Page 146
Shown above are the recordings from a cold sensor in response to a sudden lowering of the local skin temperature. Note that the initial change in temperature evokes the greatest response. This is termed the dynamic response. The steady-state response related to the fixed skin temperature. This is termed the static response. Note that this becomes 'bursting' in character at the lowest steady-state temperature shown.
Page 147
This illustration further shows the concept of dynamic and static responses from skin thermoreceptors. You can see that the nerve fibres show a greater firing rate at the initial drop in temperature (dynamic effect) than with the sustained steady temperature (static effect). Note also that as the skin temperature is raised again, the firing rate falls to zero.
White dots: cold receptors Black dots: warm receptors The static or steady-state firing rate of each individual skin thermoreceptor tends to peak at a particular skin temperature. The diagram above shows a cold sensor that happens to peak at around 30 C, and a warm sensor that happens to peak at 39 C. Note how the cold receptor fires again at 45 C and peaks for a second time at 50 C. This is a pathological temperature and relates to actual 'thermal pain'. Another piece of evidince that allows us to differentiate skin thermoreceptors is that we, as humans can clearly recognise a difference between a feeling of cold or warmth on our skin. Distribution of skin thermoreceptors is highly individualistic.
Page 148
There is a clear difference between heat production of the body at rest and during exercise. Also notice that fraction of body weight has little bearing on the production of body core heat and these variables are reliant on other metabolic factors. (There are a couple of tables here that I didn't include from the lecture slides. Look them up if you want, I don't think they're really necessary.)
Page 149
Heat passes most rapidly from the body core to the body shell by the controlled circulation of the blood. Heat conservation can be aided by shunting blood through deep-lying tissues where heat passing from the core via arteries may be transferred to deep veins and kept from escaping so rapidly. Make sure you are able to explain this because it will very likely be on the exam! On the other hand, heat loss is aided by allowing blood to pass through more superficial vessels closer to the skin surface. Note the location of the shunt in the next diagram:
Page 150
Skin vasculature is composed of a network of large arterioles and venules in the deep dermis, which send branches to a superficial network of smaller arterioles and venules. Arterio-venous anastomoses allow direct flow from arterioles to venules and greatly increase blood flow when dilated. When closed, arterio-venous anastomoses re... CHECKING WITH PROF MASKREY ON THIS POINT. Capillary loops into the dermal papillae beneath the epidermis are supplied and drained by microvessels of the superficial dermal vasculature.
Body heat is lost to the air and to other molecules in contact with the skin. Conduction of heat in water is ~20 times that in air of the same temperature. Heat so lost can then be removed from the vacinity of the skin surface by convection. Free convection occurs when air heats and becomes less dense, whereas forced convection occurs where wind or a similar force disrupts the boundary layer of air next to the skin. Free convection is passive, it relies on the surrounding air warming up, becoming less dense and more buoyant and moving away.
Page 152
Passive, uncontrolled evaporative heat loss occurs through insensible perspiration. 14. This is the diffusion of small amounts of water from the skin and upper respiratory tract 15. 600-900 grams of water are lost daily 16. Half from the skin, half from the upper respiratory tract Sweating, on the other hand, is highly regulated, active evaporative heat loss mechanism. It relies on the presence of eccrine sweat glands located within the dermis of the skin. When ambient temperature exceeds core temperature, this is the only means of losing heat for the body.
Page 153
The figure above demonstrates that it is indeed body core temperatures, not skin temperature, that determines sweat rate. This is appropriate as the role of sweat evaporation is to cool the skin. A cool skin would would inhibit sweating if this were controlled by skin thermoreceptor input. So to make it clear, nerve endings that exist in the skin that are responsible for cold and warm sensations are for sensory awareness and integration at the hypothalamus. The thermoreceptors that are responsible for the sweat response exist inside the body core, not in the skin.
Note that the relative contribution from evaporation increases as ambient temperature rises towards that of the body core. (It goes from 0.13 to 0.27 to 1.0 of total heat loss mechanisms). Do you REALLY understand the difference between radiation and convection? If you don't, read up on it.
Page 154
Note that in exercise, as opposed to the situation while at rest, heat loss via convection and conduction always exceed that due to radiation. This is because the action of the body, particularly the limbs, moving through the air substantially increases the amount of heat loss through forced convection. As with the resting subject, the proportion of heat lost through evaporation increases as the body core temperature increases.
Introduction to Pharmacology
Pharmacological Principles
Aims of this section: To define a drug To define the terms pharmacodynamics and pharmacokinetics To provide some basic pharmacology terminology To understand how drug side effects occur To understand what drug interactions are and why they can be dangerous What is so different about the elderly? Pharmacology in the elderly is unique, because old age is associated with chronic diseases and disabilities, which in turn require multiple medications.
What is a drug?
Is insulin a drug? Yes and no. Yes, when it has been administered into the body. No, when it is occurring naturally in the body (where it is simply termed a hormone). Pharmacodynamics: What the drug does to the body: binds to a receptor, causes a cellular change and then a systemic response. Specific to the drug, or class of drugs. Pharmacokinetics: What the body does to the drug; drug absorption, transport, metabolism, and elimination. Not specific to drug or class, describes a general process.
Page 155
More terminology
AGONIST = will stimulate the receptor into action. ANTAGONIST = will block the receptor, usually without causing any cellular effect. PARTIAL AGONIST/ANTAGONIST = only partially blocks or stimulates the receptor. REVERSIBLE = after drug dissociation, the receptor is still functioning.
Page 156
IRREVERSIBLE = the drug does not dissociate. The bound drug and receptor are usually internalised into the cell and broke down. The receptor function will not be restored until a new receptor protein is made and replaced into the membrane (e.g. aspirin). POTENCY = the amount of chemical required to produce an effect. The affinity or strength of binding will determine the concentration required to produce a response. Or, the better the drug binds to the receptor, the greater the effect, usually means less drug is required to be administered. i.e. drug potency is how well a drug works! SELECCTIVITY/SPECIFICITY = the narrowness of a drugs range of actions, or how well the drug recognises its intended receptor. SIDE EFFECT/ADVERSE DRUG REACTION = a drug effect that was not the primary purpose for administering the drug. Side effects may be beneficial or harmful, and may differ between patients. That is, not all patients will always get all known side effects. This may be due to the patients health, other medications, or other factors. Can be due to pharmacodynamics (e.g. low drug specificity) Can be due to pharmacokinetics (e.g. active drug metabolites) DRUG-DRUG INTERACTIONS = a health outcome caused by the interaction of two or more drugs in the system. May be due to pharmacodynamics or pharmacokinetics or both. The effect of one or both drugs can be either potentiated (enhanced) or inhibited Pharmacodynamics example: two drugs that operate at the same receptor, or set off the same cellular signalling pathway (e.g., GTN and Viagra) Pharmacokinetics example: two drugs that are metabolised by the same enzymes in the liver. One drug may inhibit or potentiate the enzyme (e.g., the broad spectrum antibiotic clarithromycin potentiates the anti-coagulant, warfarin
Polypharmacy
Polypharmacy is a huge problem in the aged. It is the administration of two or more drugs at the same time. The key example is the triple whammy: aspirin, diuretic and ACEI (anti-platelet and anti-hypertensives) one of the most common causes of hospital admission for medication-induced (iatrogenic) renal failure, and often fatal.
Drug delivery
Aims of this section: To gain knowledge of the different types of drug delivery o to understand why there are different oral formations o to understand the meaning of parenteral administration To understand that different types of drug delivery are based on pharmacokinetics and pharmacodynamics To gain a basic understanding of the factors that influence drug absorption To understand the factors that need to be considered in drug prescription
The route of drug delivery can be influenced by both pharmacodynamics and pharmacokinetics. Pharmacodynamics: o what the drug does to the body o binds to a receptor, causes a cellular and then systemic response Pharmacokinetics: o what the body does to the drug o drug absorption, transport, metabolism and elimination (e.g. the liver inactivates many drugs, so they cannot be administered orally)
Drug delivery devices include inhalers, needles, and tablets and capsules.
That is, drugs may be liquids, solids or gases. Pharmaceutics is the science of formulating drugs into different types of preparations.
Page 158
Oral administration
Used for about 75% of all drugs. Can be solid or liquid.
Solids (tablets)
About 60% of all oral drugs Must disintegrate before dissolving Once dissolved, the drug is available for absorption The more rapid the dissolution, the more readily available it is for absorption
Tablets are compressed mixture of the active ingredient, plus excepients. Excepients are inert chemicals, that include: diluents lubricants absorbents binders adhesives disintegrants flavours colours sweeteners all covered in a film to mask the taste. Also used is sublingual (dissolution) administration, and effervescent tablets that dissolve in water. The rates of release of oral tablets can be controlled by their formation: sustainable release or controlled release preparations o the active ingredient is mixed with a resin or compound which slows release enteric coatings o tablet is coated with a substance that protects it from the digestive action of the stomach o this prevents decomposition of drugs sensitive to gastric acid (e.g. penicillin and erythromycin are unstable in an acidic pH) o prevents dilution of the drug before it reaches the small intestine o prevents nausea and vomiting induced by some drugs that effect the stomach o delays the action of the drug
Parenteral administration
These are where drugs are administered by injection. This is the most rapid form of systemic therapy, and it avoids the delay in drug absorption. Drug formation for parenteral administration must be: sterile particle free o (injections of solids can cause granulomas, inschemia or phlebitis) isotonic with body solutions (e.g. diluted in normal saline) buffered to body pH
o o o o o o
what does the drug do and how does it act? how long will the patient need to be treated for? how will you monitor therapy? how much drug should be given? what is special about this patient? what other medications are they taking?
at
the
receptor
can
vary
depending
on
the
drug-target
Agonist (stimulating) or antagonists (blocking) o Both are either competitive (reversible) or irreversible, where the drug binds, but does not let go, so the receptor needs to be replaced by the cell. Aspirin is an example of this. Partial agonists Allosteric modulators can modulate a protein (change how it acts) Enzyme inhibitors/activators o Enzymatic inhibitor normal reaction inhibited o Fals substrate abnormal metabolite o Pro-drug active drug produced Non-specific
Page 160
Use-dependent drugs Drugs that only exert their therapeutic effect at receptors that are or have been activated. Examples: o Beta-blockers, commonly used to treat hypertension and angina Block the action of adrenaline and noradrenaline at beta-receptors They have no antagonistic function in a person at rest because there is no adrenaline or noradrenaline present o Sodium channel blockers, commonly used to treat dysrhythmias in the heart Block the sodium channels when they are in their open or refractory (unable to be activated) state, not when they are at rest
4. Nuclear-linked receptors Each of the four receptor superfamilies have defined modes of signal transduction.
Ligand gates is the same as chemical-gated. Chemically-gated, voltage-gated and leakage ion channels govern changes in membrane potential. Chemically-gated (ligand-gated), voltage-gated and leakage ion channels govern changes in membrane potentials.
Page 162
Ion channel opening and closing mechanisms Receptors may be activated by binding at specific sites: o for example, calcium channel blockers o important for hypertension, angina and some heart arrythmias o three classes, each act at a separate binding site on the same subunit
G-protein-coupled receptors
G-proteins have seven proteins wound through the plasma membrane C-terminus (tail) inside the cell (the COOH end) N-terminus (head) outside the cell, ligand binds to this (the NH2 end) Very important, likely to be on the exam: 1. GDP is exchanged for GTP and the alpha and beta-gamma subunits split, activating 1 or 2 targets 2. GTP hydrolysis deactivates the g-protein subunits 3. the GTPs can either activate targets 1 and 2 or inhibit them 4. Target 1 and 2 can be: a. ion channels b. guanylate cyclase c. adenylate cyclase, or d. phospholipase C
Page 163
Kinase-linked receptors
Dimerisation and autophosphorylation activates kinase-linked receptors.
Page 164
Nuclear-linked receptors
Steroid receptor activation can stimulate the up- or down-regulation of protein synthesis.
Ion channels
Ion channels form the basis of cell communication. They are integral membrane proteins (usually five joined together) They have hydrophilic regions of the proteins lining the inside of the channel, and the hydrophobic region exposed to the lipid membrane The charge of the hydrophilic region determines which ions may pass Nongated ion channels are open all the time and are termed leakage channels Gated ion channels have some sort of barrier Voltage-gated ion channels: open in response to a change in the membrane voltage, and are essential in action potential generation and conduction Ligand-gated ion channels: open in response to chemical stimuli, such as neurotransmitters, hormones or other ions that bind the channel, causing it to open; involved in synaptic transmission.
Page 166
Leakage channels: have gates that randomly open, and are involved in the maintenance of the membrane potential at rest. Mechanoreceptors: gated ion channels that open in response to mechanical stimulation, such as touch and vibration.
Page 167
Potassium is essential for the resting membrane potential. The resting membrane potential is established when the tendency for K+ to move out of the cell because of the concentration gradient, is equal to the tendency for K+ to move into the cell because of the electrical gradient (the attraction of the positively charged K+ to the negatively charged proteins and ions within the cell).
Page 169